Yayınlar & Eserler

Yayın Ağı
Makaleler 206
Tümü (206)
SCI-E, SSCI, AHCI (180)
SCI-E, SSCI, AHCI, ESCI (192)
ESCI (12)
Scopus (194)
TRDizin (33)
Diğer Yayınlar (4)

1. Illness-related communication experiences of mothers of children with cancer during the end of life

KEBUDİ R., AYDIN A., Dalkılıç Bingöl H., ERTUNÇ SOYCAN M., YILDIRIM Ü. M., Koç Şenol B., et al.
BMC Palliative Care , cilt.24, sa.1, 2025 (SCI-Expanded, SSCI, Scopus) identifier identifier

2. Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional Study

Wheeler A. P., Abraham A., Barnes C., Brown Frandsen R., d'Oiron R., Eichler H., et al.
Haemophilia , cilt.31, sa.5, ss.903-911, 2025 (SCI-Expanded) identifier

3. Keeping Hope for Dying Children and Their Families: The Experiences of Physicians and Nurses in Pediatric Oncology

Bingöl H. D., Aydın A., Kebudi R., Ertunç Soycan M., Yıldırım Ü. M., Şenol B. K., et al.
Pediatric Blood and Cancer , cilt.72, sa.8, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

4. Advances in Pediatric Lymphoblastic Lymphoma: Demographic, Clinical Characteristics, Treatment and Long-Term Outcome: A Single-Center Retrospective Analysis

YILDIRIM Ü. M., KEBUDİ R., Koç Şenol B., ZÜLFİKAR O. B.
Turkish Archives of Pediatrics , cilt.60, sa.4, ss.379-383, 2025 (ESCI) identifier identifier identifier

5. Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Young G., Kavakli K., Klamroth R., Matsushita T., Peyvandi F., Pipe S. W., et al.
Blood , cilt.145, sa.25, ss.2966-2977, 2025 (SCI-Expanded) identifier identifier

6. Religious Coping Strategies of Mothers Who Lost Their Children to Cancer in Türkiye: A Qualitative Study

AYDIN A., Bingöl H., KEBUDİ R., Savaş E. H., Koç B., Büyükkapu Bay S., et al.
Journal of Religion and Health , cilt.64, sa.3, ss.2152-2164, 2025 (AHCI) Sürdürülebilir Kalkınma identifier

7. Comparison of Capizzi and High-dose Methotrexate Approaches in the Treatment of Pediatric B-cell Acute Lymphoblastic Leukemia

Gungoren E. Y., Koc B., ZÜLFİKAR O. B.
Journal of Pediatric Hematology/Oncology , cilt.47, sa.2, ss.67-73, 2025 (SCI-Expanded) identifier identifier

8. Inflammatory myofibroblastic tumors in children: clinical characteristics and treatment outcomes with a focus on targeted therapies

YILDIRIM Ü. M., KEBUDİ R., ZÜLFİKAR O. B., Bilgiç B.
Turkish Journal of Pediatrics , cilt.67, sa.1, ss.51-60, 2025 (SCI-Expanded) identifier identifier

9. Thyroid Cancer in Childhood Cancer Survivors: Demographic, Clinical, Germline Genetic Characteristics, Treatment, and Outcome

YILDIRIM Ü. M., KEBUDİ R., İribaş Çelik A., ZÜLFİKAR O. B., Kebudi A.
Journal of Clinical Medicine , cilt.14, sa.2, 2025 (SCI-Expanded) identifier identifier

10. Repeated Radiosynovectomy in Haemophilia: Revealing Long-Term Effectiveness and Safety

Koc B., Turkmen C., Polat G., ZÜLFİKAR O. B.
Haemophilia , cilt.31, sa.1, ss.156-161, 2025 (SCI-Expanded) identifier identifier

11. The Understanding of the Importance of Oxidant/antioxidant Status in Hemophilia Patients with Arthropathy

BİNGÜL İ., Senol B. K., Hanikoglu A., Delen E., Omer B., Genc N. S., et al.
Indian Journal of Hematology and Blood Transfusion , 2025 (SCI-Expanded, Scopus) identifier

12. Predominance of Radiographical Femoral Component Loosening Signs in Total Knee Arthroplasty for Hemophilic Arthropathy

Koç B., ZÜLFİKAR O. B., Arzu U., Atasoy İ. T., Ege M., POLAT G.
Haemophilia , 2025 (SCI-Expanded) identifier identifier

13. Experiences of Health Care Professionals in Navigating Challenges of Pediatric Cancer Recurrence

Dalkılıç Bingöl H., AYDIN A., KEBUDİ R., ERTUNÇ SOYCAN M., YILDIRIM Ü. M., Koç Şenol B., et al.
Journal of Palliative Medicine , 2025 (SCI-Expanded) identifier identifier identifier

14. Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises in Improving Balance and Gait in People With Hemophilia: Protocol for a Randomized Controlled Trial

Isleyen T. P., TARAKCI E., Leblebici G., YELDAN KARAGÖZ İ., ZÜLFİKAR O. B.
JMIR Research Protocols , cilt.14, 2025 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

15. Fertility Preservation in Postpubertal Males Undergoing Cancer Treatment in a Middle-Income Country: Is it Possible Despite the Barriers?

YILDIRIM Ü. M., KEBUDİ R., Bingöl H. D., Şenol B. K., ZÜLFİKAR O. B.
Turkish Archives of Pediatrics , cilt.59, sa.6, ss.543-546, 2024 (ESCI) identifier identifier

16. Common viral respiratory infections in children with cancer during the COVID-19 pandemic: a multicenter study from Türkiye

Kaçar D., KEBUDİ R., Özyörük D., Tuğcu D., BAHADIR A., ÖZDEMİR Z. C., et al.
The Turkish journal of pediatrics , cilt.66, sa.4, ss.401-411, 2024 (Scopus) identifier identifier identifier

17. Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options

ZÜLFİKAR O. B., Koç B., Şahin F., ŞAŞMAZ H. İ., Kavaklı K., Balkan C., et al.
Research and Practice in Thrombosis and Haemostasis , cilt.8, sa.7, 2024 (SCI-Expanded) identifier

18. Joint by Joint Correlations Between Ultrasound HEAD-US Scores and HJHS Joint Scores in Hemophilia A Patients: A National, Multi-Center, Prospective, and Cross-Sectional Study Hemofili A Hastalarında Ultrason HEAD-US ve HJHS Eklem Skorları Arasındaki Korelasyon: Ulusal, Çok Merkezli, Prospektif ve Kesitsel Bir Çalışma

Kavaklı R. K., Tamsel İ., Balkan C., Antmen A. B., Akbaş T., Şaşmaz H. İ., et al.
Türkiye Klinikleri Tıp Bilimleri Dergisi , cilt.44, sa.3, ss.97-104, 2024 (Scopus) Creative Commons License

19. Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A

Malec L., Peyvandi F., Chan A. K., Königs C., ZÜLFİKAR O. B., Yuan H., et al.
New England Journal of Medicine , cilt.391, sa.3, ss.235-246, 2024 (SCI-Expanded) identifier identifier identifier

20. Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors.

Zülfikar B., Mahlangu J., Nekkal S. M., Ross C., Uaprasert N., Windyga J., et al.
TH open : companion journal to thrombosis and haemostasis , cilt.8, sa.3, 2024 (Hakemli Dergi) identifier

21. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Kenet G., Nolan B., ZÜLFİKAR O. B., Antmen B., Kampmann P., Matsushita T., et al.
Blood , cilt.143, sa.22, ss.2256-2269, 2024 (SCI-Expanded) Creative Commons License identifier identifier

22. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

Fischer K., Lassila R., Peyvandi F., Gatt A., Gouw S. C., Hollingsworth R., et al.
Research and Practice in Thrombosis and Haemostasis , cilt.8, sa.4, 2024 (SCI-Expanded) identifier identifier

23. Concizumab prophylaxis in persons with hemophilia A or B with inhibitors: patient-reported outcome results from the phase 3 explorer7 study

Tran H., von Mackensen S., Abraham A., Castaman G., Hampton K., Knoebl P., et al.
Research and Practice in Thrombosis and Haemostasis , cilt.8, sa.4, 2024 (SCI-Expanded) identifier identifier

24. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.

Matsushita T., Shapiro A., Abraham A., Angchaisuksiri P., Castaman G., Cepo K., et al.
The New England journal of medicine , cilt.389, sa.9, ss.783-794, 2023 (SCI-Expanded) identifier

25. What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?

Mert L., Bilgiç B., Şenol B. K., Zülfikar O. B., Durmaz H., Polat G.
Clinical orthopaedics and related research , cilt.481, sa.8, ss.1634-1647, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

26. Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial

Leebeek F. W. G., Peyvandi F., Tiede A., Castaman G., Escobar M., Wang M., et al.
European Journal of Haematology , cilt.111, sa.1, ss.29-40, 2023 (SCI-Expanded) identifier identifier

27. Medical and Socio-Psychological Consequences of the COVID-19 Pandemic on People with Congenital Bleeding Disorders and Their Caregivers

ZÜLFİKAR H., KOÇ ŞENOL S. B., Gözüpek G., ZÜLFİKAR O. B.
Istanbul University/ CURARE Journal of Nursing , cilt.0, 2023 (Hakemli Dergi) Creative Commons License

28. The Effects of Coronavirus Disease 2019 Pandemic on Patients with Hemophilia and Inherited Bleeding Disorders: Results from 2 Centers in Turkey

GÜRLEK GÖKÇEBAY D., KOÇ ŞENOL S. B., Kurtipek F. B., Koşan Çulha V., ÖZBEK N. Y., ZÜLFİKAR O. B.
TURKISH ARCHIVES OF PEDIATRICS , 2023 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

29. The Effects of Exercise Training on Physical Activity Level, Daily Living Activities, and Participation in Children with Hemophilia

ATAY C., TARAKCI E., YELDAN İ., ZÜLFİKAR B.
Turkish archives of pediatrics (Online) , cilt.58, sa.3, ss.274-281, 2023 (Scopus) identifier identifier identifier

30. REDUCED VOLUME AND FASTER INFUSION RATE OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE: A RANDOMIZED PHASE 3B/4 TRIAL IN ADULTS WITH HEMOPHILIA A OR B

Zulfikar B., Mahlangu J., Nekkal S. M., Ross C., Uaprasert N., Windyga J., et al.
HAEMOPHILIA , ss.140-141, 2023 (SCI-Expanded) identifier

31. PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE: POST HOC ANALYSIS FROM A PHASE 3 TRIAL

Leebeek F. W. G., Escobar M., Tiede A., Wang M., Zulfikar B., Wang S., et al.
AMERICAN JOURNAL OF HEMATOLOGY , 2023 (SCI-Expanded) identifier

32. TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HAEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY

Hampton K., Knoebl P., Neergaard J. S., Odgaard-Jensen J., Stasyshyn O., Zaw J. J. T., et al.
HAEMOPHILIA , ss.77-78, 2023 (SCI-Expanded) identifier

33. EFFECT OF BEVACIZUMAB ON CARTILAGE AND SYNOVIUM IN HEMOPHILIC ARTHROPATHY: AN EXPERIMENTAL ANIMAL STUDY

Mert L., Bilgic B., KOÇ ŞENOL S. B., Zulfikar B., Durmaz H., Polat G.
HAEMOPHILIA , ss.37-38, 2023 (SCI-Expanded) identifier

34. IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN

Kebudi R., Buyukkapu S. B., Yildirim U. M., Salduz A.
PEDIATRIC BLOOD & CANCER , cilt.69, 2022 (SCI-Expanded) identifier

35. BEREAVEMENT EXPERIENCES OF MOTHERS AFTER THE DEATH OF A CHILD WITH CANCER: IS A NEW BEGINNING POSSIBLE?

Aydin A., Bingol H., Kebudi R., Umac E. H., Koc S. B., Buyukkapu S. B., et al.
PEDIATRIC BLOOD & CANCER , cilt.69, 2022 (SCI-Expanded) identifier

36. RB1 GENE MUTATIONS IN TURKISH PATIENTS WITH RETINOBLASTOMA

Odemis D. A., Kebudi R., Erciyas S. K., Turkcan G. K., Tuncer S., Erdogan O. S., et al.
PEDIATRIC BLOOD & CANCER , cilt.69, 2022 (SCI-Expanded) identifier

37. Desires vs. conditions: A qualitative study exploring the factors affecting the place of death of child with cancer in Turkey

Bingol H., Aydin A., Kebudi R., Umac E. H., Koc B., Yildirim Ü. M., et al.
EUROPEAN JOURNAL OF CANCER CARE , cilt.31, sa.6, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

38. NONCOVID-19 VIRAL RESPIRATORY INFECTIONS IN CHILDREN WITH CANCER DURING THE COVID-19 PANDEMIC: A MULTICENTER OBSERVATIONAL STUDY

Kebudi R., Kacar D., Ozyoruk D., Tugcu D., Yarali N., Ilhan I., et al.
PEDIATRIC BLOOD & CANCER , cilt.69, 2022 (SCI-Expanded) identifier

39. Comparison of analgesic consumption of hemophilic and non-hemophilic patients in knee arthroplasty.

Canbolat N., Dinç T., Koltka K., Zülfikar O. B., Koç B., Kılıçoğlu Ö. İ., et al.
Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES , cilt.28, sa.11, ss.1616-1621, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

40. Gene therapy in haemophilia: literature review and regional perspectives for Turkey

Kavakli K., Antmen B., Okan V., ŞAHİN F., AYTAÇ EYÜPOĞLU Ş. S., BALKAN C., et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY , cilt.13, 2022 (SCI-Expanded) identifier identifier identifier

41. Efficacy and safety of outpatient based therapy in childhood acute lymphoblastic leukemia.

Zulfikar O. B., Koc B.
JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded) identifier

42. RB1 gene mutations in Turkish retinoblastoma patients.

Kebudi R., Akdeniz D., Bayramova J., Erciyas S. K., Turkcan G. K., Tuncer B. S., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded) identifier

43. COVID-19 experience with inherited bleeding disorders similar to the country population

Koc B., Zulfikar B.
HAEMOPHILIA , cilt.28, ss.32, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

44. PATIENT-ORIENTED APPROACH IN THE MANAGEMENT OF HEMOPHILIA; A MULTICENTER SURVEY ON INJECTIONS WITHOUT A VIAL IN PLACE

Zulfikar H., Koc B., Ciga F., Zulfikar B.
HAEMOPHILIA , cilt.28, ss.76-77, 2022 (SCI-Expanded) identifier

45. Results of multicenter registry for patients with inherited factor VII deficiency in Turkey

AKDENİZ A., Unuvar A., AR M. C., Pekpak E., AKYAY A., MEHTAP Ö., et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION , cilt.82, sa.1, ss.28-36, 2022 (SCI-Expanded) identifier identifier identifier

46. MEDICAL AND SOCIO-PSYCHOLOGICAL EFFECTS OF THE PANDEMIC ON PATIENTS WITH HEREDITER BLEEDING DISORDERS AND THEIR TREATERS

Zulfikar B., Zulfikar H., Gozudok G., Koc B.
HAEMOPHILIA , cilt.28, ss.72, 2022 (SCI-Expanded) identifier

47. New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains

KÖKER M. Y., Sarper N., Albayrak C., Zulfikar B., ZENGİN E., Saraymen B., et al.
PLATELETS , cilt.33, ss.551-561, 2022 (SCI-Expanded) identifier identifier identifier

48. Nasopharyngeal carcinoma in children: Multimodal treatment and long-term outcome of 92 patients in a single center over a 28-year period

Kebudi R., Buyukkapu S. B., Gorgun O., Ozkaya K., Meral R., Ayan I., et al.
PEDIATRIC BLOOD & CANCER , cilt.68, sa.12, 2021 (SCI-Expanded) identifier identifier identifier

49. Second malignancies in children with head and neck primary tumors.

Kebudi R., Buyukkapu S. B., Gorgun O., Iribas A., Agaoglu F. Y., Kebudi A., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded) identifier

50. Inherited Rare Factor Deficiencies: Single-centre Experience

Koc B., Zulfikar B.
MEANDROS MEDICAL AND DENTAL JOURNAL , cilt.22, sa.1, ss.1-6, 2021 (ESCI) identifier identifier

51. Persons With Hemophilia of Generation Y and Their Relatives Attitudes and Expectations From Treatment

Zulfikar B., Koc B., Gumustas I., Zulfikar H.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.27, 2021 (SCI-Expanded) identifier identifier identifier

52. A CROSS-SECTIONAL STUDY: RENAL FUNCTIONS IN ADULTS AND CHILDREN WITH HAEMOPHILIA

Zulfikar B., Koc B., Yildiz M.
HAEMOPHILIA , cilt.27, ss.37, 2021 (SCI-Expanded) identifier

53. INHERITED RARE FACTOR DEFICIENCIES: SINGLE CENTER EXPERIENCE

Koc B., Zulfikar B.
HAEMOPHILIA , cilt.27, ss.158, 2021 (SCI-Expanded) identifier

54. Flow cytometric analysis of platelet surface glycoproteins in the diagnosis of thirty-two Turkish patients with Glanzmann thrombasthenia: a multicenter experience

SARAYMEN B., MUHTAROĞLU S., KÖKER M. Y., SARPER N., ZENGİN E., ALBAYRAK C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.2136-2141, 2021 (SCI-Expanded) identifier identifier identifier identifier

55. A Challenge for Hemophilia Treatment: Hemophilia and Cancer.

Koc B., Zulfikar B.
Journal of pediatric hematology/oncology , cilt.43, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

56. Impact of the HEAD-US Scoring System for Observing the Protective Effect of Prophylaxis in Hemophilia Patients: A Prospective, Multicenter, Observational Study

Kavakli K., ÖZBEK S. S., Antmen A. B., ŞAHİN F., AYTAÇ EYÜPOĞLU Ş. S., Kupesiz A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.2, ss.101-110, 2021 (SCI-Expanded) identifier identifier identifier identifier

57. Acute Complications and Survival Analysis of Childhood Acute Lymphoblastic Leukemia: A 15-year Experience.

Öztürk A. P., Koç B., Zülfikar B.
Clinical lymphoma, myeloma & leukemia , cilt.21, 2021 (SCI-Expanded) identifier identifier identifier

58. Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives

İncesoy Özdemİr S., Taçyıldız N., Varan A., Kebudi R., Zülfikar O. B., Celkan T. T., et al.
Turkish journal of medical sciences , cilt.50, ss.1916-1921, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

59. Rhabdomyosarcoma in an Adolescent Boy With Bone Marrow Infiltration

Zulfikar B., Koc B., Bay S. B., Aki H.
PEDIATRIC BLOOD & CANCER , cilt.67, 2020 (SCI-Expanded) identifier

60. Thrombotic Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia

Zulfikar B., Koc B., Ozturk P.
PEDIATRIC BLOOD & CANCER , cilt.67, 2020 (SCI-Expanded) identifier

61. Prognostic factors of radiosynovectomy in haemophilia patients with inhibitors: Survival analysis in a 19-year period

Koc B., Kilicoglu O., Turkmen C., Zulfikar B.
HAEMOPHILIA , cilt.26, sa.5, ss.855-860, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

62. Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A

Chowdary P., Mullins E. S., Konkle B. A., McGuinn C., Park Y. S., Stasyshyn O., et al.
HAEMOPHILIA , cilt.26, sa.4, 2020 (SCI-Expanded) identifier identifier identifier

63. Oral surgical approaches in patients with bleeding disorders

Gunay A. Y., Zulfikar B.
HAEMOPHILIA , cilt.26, ss.47, 2020 (SCI-Expanded) identifier

64. Correlation between HJHS and HEAD-US Scores during Prophylaxis in Turkish Patients with Hemophilia: National Prospective Observational Study

Kavakli K., Antmen B., AYTAÇ EYÜPOĞLU Ş. S., ŞAHİN F., Zulfikar B., SÖNMEZ M., et al.
HAEMOPHILIA , cilt.26, ss.53-54, 2020 (SCI-Expanded) identifier

65. Clinical problems and surgical interventions in inherited factor VII deficiency

Senol B. K., Zulfikar B.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.55, sa.2, ss.184-190, 2020 (ESCI) identifier identifier identifier

66. Peer Education Project of the Haemophilia Society of Turkey

Bezgal F., Zulfikar H., Gumustas I., Koc B., Zulfikar B.
HAEMOPHILIA , cilt.26, ss.101-102, 2020 (SCI-Expanded) identifier

67. RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES

Windyga J., Collins P., Escuriola-Ettingshausen C., Escobar M., Shapiro S., Zulfikar B., et al.
HAEMOPHILIA , cilt.26, ss.25, 2020 (SCI-Expanded) identifier

68. PHARMACOKINETIC-GUIDED PROPHYLAXIS BASED ON BAYESIAN MODEL WITH MYPKFIT (R) IN HEMOPHILIA A: TURKISH EXPERIENCE

Balkan C., Albayrak C., Koc B., Ozdemir G. N., Ozbek N. Y., Aytac S., et al.
HAEMOPHILIA , cilt.26, ss.62, 2020 (SCI-Expanded) identifier

69. HARMONY IN MARRIAGE AND SEXUAL LIFE IN WOMEN IN FAMILIES WITH HAEMOPHILIA AND WOMEN IN FAMILIES WITHOUT HAEMOPHILIA

Gumustas I., Koc B., Zulfikar B.
HAEMOPHILIA , cilt.26, ss.58-59, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

70. CIRCUMCISION IN HAEMOPHILIA WITH INHIBITORS DURING EMICIZUMAB PROPHYLAXIS

Zulfikar B., Koc B., Kara C.
HAEMOPHILIA , cilt.26, ss.61-62, 2020 (SCI-Expanded) identifier

71. Successful Hemostasis with Extended Half-life Recombinant Factor VIII in Circumcision

Koc B., Ozturk M. I., Zulfikar B.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.1, ss.62-63, 2020 (SCI-Expanded) identifier identifier identifier

72. Evaluation of Chromogenic Factor VIII Assay Compared with One-Stage Clotting Assay

Akkaya E., Hatiboglu S., Koc B., Genc S., Unuvar A., Karaman S., et al.
CLINICAL LABORATORY , cilt.66, sa.10, ss.1937-1943, 2020 (SCI-Expanded) identifier identifier identifier

73. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience

Bay S. B., Kebudi R., Gorgun O., Zulfikar B., Darendeliler E., ÇAKIR F. B.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.6, ss.1343-1348, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

74. Low-dose Immune Tolerance Induction in Hemophilia: A Single-Center Experience

Zulfikar B., Koc B., Ozdemir N.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.41, sa.6, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

75. Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia

Yildiz M., Ozdemir N., Onal H., Koc B., Tipici B., Zulfikar B.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , cilt.11, sa.2, ss.173-180, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier identifier

76. Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency

Bay S. B., Kebudi R., Zulfikar B.
MELANOMA RESEARCH , cilt.29, sa.1, ss.99-101, 2019 (SCI-Expanded) identifier identifier identifier

77. Survival analysis of radiosynovectomy in the hemophilia with inhibitors: An 18-year retrospective review

Zulfikar B., Turkmen C., Koc B., Kilicoglu O.
HAEMOPHILIA , cilt.25, ss.62, 2019 (SCI-Expanded) identifier

78. Plasminogen deficiency with ligneous gingivitis and periodontitis

Bayar O., Yurtseven A., Koc B., Zulfikar B., Ak G.
HAEMOPHILIA , cilt.25, ss.25, 2019 (SCI-Expanded) identifier

79. Nasopharengeal Carcinoma in Children and Adolescents 1990-2018: Demographic, Clinical, Therapeutical Characteristics and Long Term Outcome of 97 Patients in a Single Institution

Kebudi R., Altun M. C., Bay S. B., Gorgun O., Ayan I., Meral R., et al.
PEDIATRIC BLOOD & CANCER , cilt.65, 2018 (SCI-Expanded) identifier

80. Respiratory viral infection's frequency and clinical outcome in symptomatic children with cancer: A single center experience from a middle-income country

Buyukkapu-Bay S., Kebudi R., Gorgun O., Mese S., Zulfikar B., Badur S.
TURKISH JOURNAL OF PEDIATRICS , cilt.60, sa.6, ss.653-659, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

81. Simultaneous Presentation of Wilms' Tumor and Contralateral Ganglioneuroma in a Child: Case Report and Literature Review

Bayramoglu Z., Adaletli I., Caliskan E., Kilicaslan I., Karaoglan C. S., Celik A., et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.40, sa.6, 2018 (SCI-Expanded) identifier identifier identifier

82. Turkey's model for the formation of the hemophilic arthropathy council

Koc B., Cetik G., Kilicoglu O., Turkmen C., Atalar A., Taser O., et al.
HAEMOPHILIA , cilt.24, ss.124, 2018 (SCI-Expanded) identifier

83. The effects of swimming on the social adaptation of hemophiliacs: A qualified research

Koc B., Zulfikar B., ASLAN D., BAL B., GUMUSTAS I., Zulfikar H.
HAEMOPHILIA , cilt.24, ss.163, 2018 (SCI-Expanded) identifier

84. The differences between intracranial hemorrhage in hemophilia A and hemophilia B and its outcome

Zulfikar B., Koc B.
HAEMOPHILIA , cilt.24, ss.35, 2018 (SCI-Expanded) identifier

85. Nasopharengeal carcinoma in children: Demographic, clinical, therapeutic characteristics and long term outcome of 97 patients.

Kebudi R., Altun M., Buyukkapu S. B., Gorgun O., Meral R., Ayan I.
JOURNAL OF CLINICAL ONCOLOGY , cilt.36, 2018 (SCI-Expanded) identifier

86. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement

Spena S., Garagiola I., Cannavo A., Mortarino M., Mannucci P. M., Rosendaal F. R., et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.16, sa.4, ss.778-790, 2018 (SCI-Expanded) identifier identifier identifier

87. A correlation between the genotype and clinical course in hemophilia B patients

Koc B., Colakoglu S., Berber E., Zulfikar B.
HAEMOPHILIA , cilt.24, ss.57, 2018 (SCI-Expanded) identifier

88. The treatment perspective of generation Y hemophiliacs and their relatives

Zulfikar B., Zulfikar H., Koc B., Bezgal F., Ciga F., Dadak C., et al.
HAEMOPHILIA , cilt.24, ss.61-62, 2018 (SCI-Expanded) identifier

89. Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis

Peyvandi F., Cannavo A., Garagiola I., Palla R., Mannucci P. M., Rosendaal F. R.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.16, sa.1, ss.39-43, 2018 (SCI-Expanded) identifier identifier identifier

90. Bilateral Wilms Tumor, Demographic Characteristics, Treatment and Outcome: A Multicenter Study

Kebudi R., Tugcu D., AKICI F., Celkan T., VURAL S., Tokuc G., et al.
PEDIATRIC BLOOD & CANCER , cilt.64, 2017 (SCI-Expanded) identifier

91. Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Rosendaal F. R., Palla R., Garagiola I., Mannucci P. M., Peyvandi F.
BLOOD , cilt.130, sa.15, ss.1757-1759, 2017 (SCI-Expanded) identifier identifier identifier

92. Efficacy and safety of a VWF/FVIII concentrate (wilate (R)) in inherited von Willebrand disease patients undergoing surgical procedures

Srivastava A., Serban M., Werner S., Schwartz B. A., Kessler C. M.
HAEMOPHILIA , cilt.23, sa.2, ss.264-272, 2017 (SCI-Expanded) identifier identifier identifier

93. Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Cannavo A., Valsecchi C., Garagiola I., Palla R., Mannucci P. M., Rosendaal F. R., et al.
BLOOD , cilt.129, sa.10, ss.1245-1250, 2017 (SCI-Expanded) identifier identifier identifier

94. Aort Coarctation In Severe Hemophilia B

Koc B., Yucel I. K., Celebi A., Zulfikar B.
HAEMOPHILIA , cilt.23, ss.42, 2017 (SCI-Expanded) identifier

95. An Ancient Complication of Hemophilia: Pseudotumor

Zulfikar B., Kilicoglu O., Emekli U., Koc B., Bezgal F., Kizir A.
HAEMOPHILIA , cilt.23, ss.45-46, 2017 (SCI-Expanded) identifier

96. Bilateral Cytomegalovirus Retinitis in a Child with Rhabdomyosarcoma

Zulfikar O. B., Emiroglu H. H., Kebudi R., Emiroglu M., Tuncer S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.32, sa.1, ss.31-34, 2017 (ESCI) Sürdürülebilir Kalkınma identifier identifier

97. Association of Family History with Biochemical Parameters for Deep Venous Thrombosis Development in Acute Lymphoblastic Leukemia: Results from a Developing Country

Cakir F. B., Kasap N. A., Zulfikar B., Koc B.
PEDIATRIC BLOOD & CANCER , cilt.63, 2016 (SCI-Expanded) identifier

98. Second Malignancies in Childhood Cancer Survivors

Kebudi R., Gorgun O., Ayan I., AGAOGLU F. Y., Kebudi A., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.63, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

99. Surgery in patients with von Willebrand disease

ZULFIKAR B., Koc B., AK G., DIKICI F., KARAMAN İ., ATALAR A. C., et al.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.27, sa.7, ss.812-816, 2016 (SCI-Expanded) identifier identifier identifier

100. Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

Windyga J., Dolan G., Altisent C., Katsarou O., Lopez Fernandez M. -., Zulfikar B.
HAEMOPHILIA , cilt.22, sa.5, ss.739-751, 2016 (SCI-Expanded) identifier identifier identifier

101. Family meetings in the hemophilia society of Turkey

Zulfikar B., Koc B., Ozcan H., Bezgal F., Zulfikar H., Buyukpinarbasili Y.
HAEMOPHILIA , cilt.22, ss.115-116, 2016 (SCI-Expanded) identifier

102. Regional hemophilia project in Turkey

Zulfikar B., Buyukpunarbasulu Y., Kulucoglu O., Gulsum A. K., Basak K. O. C., BERBER E., et al.
HAEMOPHILIA , cilt.22, ss.57, 2016 (SCI-Expanded) identifier

103. Difficulties in the treatment of an Infant with Hemophilia B

Ozkasap S., Dereci S., Ozdemir G. N., Zulfikar B.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.51, sa.2, ss.120-121, 2016 (ESCI) identifier identifier identifier

104. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Peyvandi F., Mannucci P. M., Garagiola I., El-Beshlawy A., Elalfy M., Ramanan V., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.374, sa.21, ss.2054-2064, 2016 (SCI-Expanded) identifier identifier identifier

105. Turkish experience with low dose of immun tolerance treatment for inhibitor patients

Kavakli K., Zulfikar B., Ay Y., Aytac S., Celkan T., Salcioglu Z., et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.14, ss.56, 2016 (SCI-Expanded) identifier

106. Patient who presented with abdominal pain and eosinophilia

Koç B., DIKME G., ÖZDEMIR N., ZULFIKAR B.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.51, sa.1, ss.57-59, 2016 (ESCI) identifier identifier

107. Hemophilic Arthropathy in Inhibitor Positive Hemophilia Patients

Zulfikar B., Kilicoglu O., Atalar A. C., Koc B., Bezgal F., Ozcan H., et al.
HAEMOPHILIA , cilt.22, ss.85-86, 2016 (SCI-Expanded) identifier

108. Immune Tolerance Induction: A Single Centre Experience

Koc B., Ozdemir N., Ozcan H., Zulfikar B.
HAEMOPHILIA , cilt.22, ss.85, 2016 (SCI-Expanded) identifier

109. Surgical Treatment of an Infected Nonunion of the Middle Third of the Femur Associated with Femoral Shortening in a Hemophilia Patient.

SALDUZ A., KAYA Ö., BALCI H. İ., Akgul T., DIKICI F., ZÜLFIKAR B., et al.
Case reports in orthopedics , cilt.2016, ss.3045262, 2016 (Hakemli Dergi) identifier

110. FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies

Fischer K., Iorio A., Hollingsworth R., Makris M.
HAEMOPHILIA , cilt.22, sa.1, 2016 (SCI-Expanded) identifier identifier identifier

111. When Can We Rely on the Inhibitor Negativity?

Koc B., Zulfikar B.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.61-63, 2016 (SCI-Expanded) identifier identifier

112. Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

Windyga J., Dolan G., Altisent C., Katsarou O., Lopez Fernandez M. -., Zulfikar B.
HAEMOPHILIA , cilt.22, sa.1, ss.110-120, 2016 (SCI-Expanded) identifier identifier identifier

113. Benefits of radial head excision in patients with haemophilia: mid-term functional results

Atalar A. C., Koc B., Birisik F., Ersen A., Zulfikar B.
HAEMOPHILIA , cilt.22, sa.1, 2016 (SCI-Expanded) identifier identifier identifier

114. POST KIDNEY TRANSPLANT EBSTEIN-BARR VIRUS ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA: A SUCCESS STORY

Cakir F. B., Tuna R., Demir A. D., Oktem F., Zulfikar B., Kebudi R.
PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded) identifier

115. CHILDHOOD EWING SARCOMA FAMILY TUMORS: 25-YEAR EXPERIENCE OF A SINGLE CENTER IN TURKEY

Kebudi R., Gorgun O., Cakir F. B., Agaoglu F. Y., Bay S. B., Koc B., et al.
PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded) identifier

116. INFECTIONS WITH RESPIRATORY VIRUSES IN CHILDREN WITH CANCER IN ISTANBUL AT THE LAST YEAR

Bay S. B., Kebudi R., Sozmen B. O., Gorgun O., Koc B., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

117. VINCRISTINE, IRINOTECAN AND TEMOZOLOMIDE TREATMENT FOR RECURRENT/PROGRESSIVE PEDIATRIC SOLID TUMORS

Kebudi R., Bay S. B., Cakir F. B., Gorgun O., Koc B., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded) identifier

118. Inhibitor development in non-severe haemophilia across Europe

Fischer K., Iorio A., Lassila R., Peyvandi F., Calizzani G., Gatt A., et al.
THROMBOSIS AND HAEMOSTASIS , cilt.114, sa.4, ss.670-675, 2015 (SCI-Expanded) identifier identifier identifier

119. THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

Koc B., Zulfikar B.
PEDIATRIC BLOOD & CANCER , cilt.62, ss.84, 2015 (SCI-Expanded) identifier

120. Prophylactic approach to reccurrent bleeding in hemophilia with inhibitors

Zulfikar B., Koc B., Ozdemir N.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.13, ss.362, 2015 (SCI-Expanded) identifier

121. Effective radyoactive synovectomy in hemophilia with inhibitors

Zulfikar B., Turkmen C., Kilicoglu O., Koc B., Atalar A. C., Bezgal F., et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.13, ss.859, 2015 (SCI-Expanded) identifier

122. EXCELLENT OVERALL SURVIVAL (100%) IN TURKISH CHILDREN WITH STANDART RISK ACUTE LYMPHOBLASTIC LEUKEMIA

Zulfikar B., Cakir F., Koc B.
PEDIATRIC BLOOD & CANCER , cilt.62, ss.92, 2015 (SCI-Expanded) identifier

123. Identification of novel vwf gene mutations in the Turkish type 2 VWD patient population

Berber E., Oymak Y., Baltaci O. F., Diz-Kucukkaya R., Zulfikar B. O., Kavakli K.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.13, ss.742-743, 2015 (SCI-Expanded) identifier

124. İnhibitör geliştiren ağır hemofili A olgularında rekombinant faktör VIIa’nın kanama profilaksisinde kullanımı: olgu sunumları

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., ÖZDEMİR G. N.
Türkiye Klinikleri , cilt.8, ss.13-15, 2015 (Hakemsiz Dergi)

125. INFECTIONS WITH RESPIRATORY VIRUSES IN CHILDREN WITH CANCER IN ISTANBUL

Kebudi R., Kapu S. B., Sozmen B. O., Ciblak M., Gorgun O., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.61, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

126. NASOPHARENGEAL CARCINOMA IN CHILDREN AND ADOLESCENTS 1989-2014: DEMOGRAPHIC, CLINICAL, THERAPEUTICAL CHARACTERISTICS AND LONG TERM OUTCOME

Kebudi R., Meral R., Gorgun O., Cakir B., Celikarslan S., Ayan I., et al.
PEDIATRIC BLOOD & CANCER , cilt.61, 2014 (SCI-Expanded) identifier

127. An examination of the symptoms of anxiety and parental attitude in children with hemophilia

Abali O., Zulfikar O. B., Karakoc Demirkaya S., Ayaydin H., Kircelli F., Duman M.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.44, sa.6, ss.1087-1090, 2014 (SCI-Expanded) identifier identifier identifier

128. Use of intravenous immunoglobulin in pediatric practice

Zulfikar B., Koc B.
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.49, sa.4, ss.282-288, 2014 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

129. Hemodiafiltration in Treatment of a Patient with Hypercalcemia and Acute Lymphoblastic Leukemia

AYGÜN F., KOÇ ŞENOL S. B., AYGÜN F. D., ÖZDEMİR G. N., ZÜLFİKAR O. B., ÇAM H.
Çocuk Dergisi , cilt.14, sa.4, ss.165-168, 2014 (Hakemli Dergi)

130. Long-term results of radiosynovectomy in the treatment of hemophilic synovitis: experience in Istanbul

Zulfikar B., Turkmen C., Kilicoglu O., ÇAKIR F. B., Koc B., Dikici F., et al.
HAEMOPHILIA , cilt.20, ss.68, 2014 (SCI-Expanded) identifier

131. Recovery and half-life of factor VIII

Koc B., Zulfikar B., Ozcan H.
HAEMOPHILIA , cilt.20, ss.52-53, 2014 (SCI-Expanded) identifier

132. Elective major surgery in hemophiliacs: Istanbul experience

Tuysuz G., Zulfikar B., Kilicoglu O., Dikici F., Koc B., Bezgal F., et al.
HAEMOPHILIA , cilt.20, ss.66, 2014 (SCI-Expanded) identifier

133. Organisational design of non-governmental organisations related to hemophilia: An example from Turkey

Buyukpinarbasili Y., BERBER E., Zulfikar H., Bezgal F., Kilicaslan S., Bali F., et al.
HAEMOPHILIA , cilt.20, ss.144, 2014 (SCI-Expanded) identifier

134. Dental treatment approach for Bernard-Soulier Syndrome: Three case reports

Ak G., Acikgoz M. M., Bayar O. F., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.131, 2014 (SCI-Expanded) identifier

135. Physical design of a hemophilia society centre: An example from Turkey

Zulfikar B., Gursoz H., Alkan A., Okumus G., Bali F., Tepe I., et al.
HAEMOPHILIA , cilt.20, ss.144, 2014 (SCI-Expanded) identifier

136. Hemophilia summer camp modelling based on a concept (MOCC): An example from Turkey

Zulfikar H., Bezgal F., Cakmakci S., Okumus G., Kilicaslan S., Aydogan A., et al.
HAEMOPHILIA , cilt.20, ss.144, 2014 (SCI-Expanded) identifier

137. Statistical evaluations on the internet usage behaviour of the individuals with hemophilia in turkey

Zulfikar H., Buyukpinarbasili Y., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.178, 2014 (SCI-Expanded) identifier

138. The impact of factor VIII concentrate on the development of inhibitors in children with severe hemophilia A: Turkish PUP registry study

Kavakli K., Unuvar A., Salcioglu Z., KILINÇ Y., Oner A. F., Ay Y., et al.
HAEMOPHILIA , cilt.20, ss.33, 2014 (SCI-Expanded) identifier

139. Evaluation of kidney function in young hemophilics

Yildiz M. E., Ozdemir N., Caliskan S., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.30, 2014 (SCI-Expanded) identifier

140. Evaluation of dental findings in Turkish national hemophilia summer camp

Ak G., Acikgoz M. M., Bayar O. F., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.131, 2014 (SCI-Expanded) identifier

141. Circumcision in Bleeding Disorders: Improvement of Our Cost Effective Method with Diathermic Knife

Karaman M. I., Zulfikar B., Ozturk M. I., Koca O., Akyuz M., Bezgal F.
UROLOGY JOURNAL , cilt.11, sa.2, ss.1406-1410, 2014 (SCI-Expanded) identifier identifier identifier

142. A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients

Fidanci I. D., Zulfikar B., Kavakli K., Ar M. C., KILINÇ Y., Baslar Z., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.1, ss.17-24, 2014 (SCI-Expanded) identifier identifier identifier

143. Operative management and outcomes in haemophilia with inhibitor

Zulfikar B., Koc B., Kilicoglu O., Turkmen C., Dikici F., Ak G., et al.
HAEMOPHILIA , cilt.20, ss.82, 2014 (SCI-Expanded) identifier

144. Choice of treatment and target parameters in von Willebrand disease (VWD) patients undergoing surgery: a survey of current practice in Europe

Windyga J., Dolan G., Altisent C., Katsarou O., Lopez-Fernandez M. -., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.66, 2014 (SCI-Expanded) identifier

145. Defining DDAVP responses in types 1 and 2 von Willebrand disease (VWD): a EUROPEAN survey

Windyga J., Dolan G., Altisent C., Katsarou O., Lopez-Fernandez M. -., Zulfikar B.
HAEMOPHILIA , cilt.20, ss.65-66, 2014 (SCI-Expanded) identifier

146. Survival analysis of Y-90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10-year retrospective review

Turkmen C., Kilicoglu Ö. İ., Dikici F., Bezgal F., Kuyumcu S., Gorgun O., et al.
HAEMOPHILIA , cilt.20, sa.1, 2014 (SCI-Expanded) identifier identifier identifier

147. ORAL CERRAHİDE HEMOFİLİ HASTALARINA GÜNCEL YAKLAŞIMLAR

Ak G., Açıkgöz M. M., Şenol Güven G., Zülfikar B.
İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi , cilt.47, sa.3, ss.33-40, 2013 (Hakemli Dergi)

148. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Gringeri A., Leissinger C., Cortesi P. A., Jo H., Fusco F., Riva S., et al.
HAEMOPHILIA , cilt.19, sa.5, ss.736-743, 2013 (SCI-Expanded) identifier identifier identifier

149. AN ADOLESCENT WITH HYPEREOSINOPHILIC SYNDROME DIAGNOSED AS CHRONIC EOSINOPHILIC LEUKEMIA WITH THE FINDING OF FIP1L1-PDGFRA MUTATION

Cakir B., Zulfikar B., Kebudi R., Dogan O.
PEDIATRIC BLOOD & CANCER , cilt.60, ss.225, 2013 (SCI-Expanded) identifier

150. Successful management of bilateral total hip replacement in a patient with von Willebrand's disease and developmental hip dysplasia

Zulfikar B., Akgül T., Özdemir N., BEZGAL F., Talu U.
Haemophilia , cilt.19, sa.5, 2013 (SCI-Expanded) identifier identifier identifier

151. EXPERIENCE ON DEEP SEDATION ANESTHESIA GIVEN TO CHILDREN WITH MALIGNANCY FOR INVASIVE PROCEDURES AT THE PEDIATRIC WARD

Cakir B., Umutoglu T., Bakan M., Topuz U., KEBUDİ R., ZÜLFİKAR O. B.
PEDIATRIC BLOOD & CANCER , cilt.60, ss.173-174, 2013 (SCI-Expanded) identifier

152. EXTRACRANIAL GERM CELL TUMORS IN CHILDREN: 23-YR EXPERIENCE OF A SINGLE CENTER

Kebudi R., Cakir F. B., Gorgun O., Uludag D., Ayan I., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.60, ss.101, 2013 (SCI-Expanded) identifier

153. Major surgery in haemophiliacs: Istanbul experience

Zulfikar B., Tuysuz G., Ozdemir N., Kilicoglu O., Aras N., Taser O.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.11, ss.529, 2013 (SCI-Expanded) identifier

154. Operative management and outcomes in patients with von willebrand disease

Zulfikar B., Koc B., Ak G., Dikici F., Karaman I., Atalar A., et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.11, ss.1184, 2013 (SCI-Expanded) identifier

155. Evaluation of unfavourable cardiovascular risk factors and metabolic syndrome in young haemophilics

Erbas M., Zulfikar B., Ozdemir N., Aydin A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.11, ss.925, 2013 (SCI-Expanded) identifier

156. Effect of Prothrombotic Mutations on Factor Consumption in Children With Hemophilia

Tuten H., Cam H., Ozdemir N., Bezgal F., Buyru N., Zulfikar B., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.19, sa.4, ss.445-448, 2013 (SCI-Expanded) identifier identifier identifier

157. The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial

Kazancioglu H. O., Cakir O., Ak G., Zulfikar B.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.1, ss.19-24, 2013 (SCI-Expanded) identifier identifier identifier

158. Long-term outcomes in haemophilic synovitis after radiosynovectomy using rhenium-186: a single-centre experience

Zulfikar B., Turkmen C., Kilicoglu Ö. İ., Dikici F., BEZGAL F., Gorgun O., et al.
HAEMOPHILIA , cilt.19, sa.2, ss.275-280, 2013 (SCI-Expanded) identifier identifier identifier

159. Current Surgical Procedures for Hemophilic Patients in Oral Surgery

AÇIKGÖZ M. M., Guven G. S., Zulfikar B., AK G.
JOURNAL OF ISTANBUL UNIVERSITY FACULTY OF DENTISTRY , cilt.47, sa.3, ss.33-40, 2013 (ESCI) identifier

160. A Rare Clinical Problem: Intestinal Pseudolymphoma in a Patient with Haemophilia A

Zulfikar O. B., Emiroglu H. H., Yekeler E., Kebudi R.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.280-281, 2013 (SCI-Expanded) identifier identifier

161. Acquired hemophilia A and the knowledge/awareness level of Turkish hematology fellows: On behalf of the Turkish Hematology Association, Acquired Hemophilia Working Group

Demir M., Unuvar A., Aksu S., Antmen B., Ar C., Baslar Z., et al.
HAEMOPHILIA , cilt.18, ss.54, 2012 (SCI-Expanded) identifier

162. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey

Zulfikar B., Aydogan G., Salcioglu Z., Oner A. F., Kavakli K., Gursel T., et al.
HAEMOPHILIA , cilt.18, sa.3, ss.383-391, 2012 (SCI-Expanded) identifier identifier identifier

163. Treatment of odontogenic large cysts in haemophiliac patients

Cakir O., Kazancioglu H. O., Ak G., Zulfikar B.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.23, sa.3, ss.253-254, 2012 (SCI-Expanded) identifier identifier identifier

164. The Evaluation of Fibrin Sealants and Tissue Adhesives in Oral Surgery Among Patients with Bleeding Disorders

Ak G., Baskirt E. A., Kurklu E., Koray M., Tanyeri H., Zulfikar B.
TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.1, ss.40-47, 2012 (SCI-Expanded) identifier identifier identifier

165. Metastatic Mandibular Neuroblastoma: A Rare Cause of Tooth Mobility

Kurklu E., Emiroglu H. H., Kebudi R., Ozdas D. O., Ayan I., Gorgun O., et al.
JOURNAL OF CLINICAL PEDIATRIC DENTISTRY , cilt.36, sa.2, ss.203-206, 2011 (SCI-Expanded) identifier identifier identifier

166. SECOND MALIGNANT TUMORS IN CHILDHOOD CANCER SURVIVORS: A CENTER'S TWENTY YEAR EXPERIENCE

Kebudi R., Ayan I., Ozdemir N., Gorgun O., Agaoglu F. Y., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.873, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

167. Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors

Leissinger C., Gringeri A., Antmen B., Berntorp E., Biasoli C., Carpenter S., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.365, sa.18, ss.1684-1692, 2011 (SCI-Expanded) identifier identifier identifier

168. The effects of repeated radioactive synovectomy on the treatment of hemophilic arthropathy

Zulfikar B., Kilicoglu O., Turkmen C., Bezgal F., Diler N., Taser O.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.9, ss.928, 2011 (SCI-Expanded) identifier

169. Sex-change surgery in a type 3 VWD patient

Zulfikar B., Gurhan O., Bezgal F., Berber E.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS , cilt.9, ss.912, 2011 (SCI-Expanded) identifier

170. Second malignant tumors in childhood cancer survivors

Kebudi R., Ayan I., Gorgun O., Agaoglu F. Y., Ozdemir G. N., Dizdar Y., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

171. The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors

Gringeri A., Antmen B., Berntorp E., Biasioli C., Carpenter S., Kavakli K., et al.
HAEMOPHILIA , cilt.17, sa.2, ss.363, 2011 (SCI-Expanded) identifier

172. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation

Zulfikar O. B., Emiroglu H. H., Kebudi R.
DIGESTIVE AND LIVER DISEASE , cilt.43, sa.3, ss.247-248, 2011 (SCI-Expanded) identifier identifier identifier

173. EXTRACRANIAL GERM CELL TUMORS IN CHILDREN: RESULTS IN 20 YEARS IN A SINGLE CENTER

Kebudi R., Ayan I., Gorgun O., Zulfikar B., Emiroglu H., Ozdemir N., et al.
PEDIATRIC BLOOD & CANCER , cilt.55, sa.5, ss.881, 2010 (SCI-Expanded) identifier

174. Circumcision of people with hemorrhagic diathesis

Zulfikar B., Karamani K., Bezgal F., Ovalif O.
HAEMOPHILIA , cilt.16, ss.11-12, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

175. The use of a new hemostatic agent: Ankaferd Blood Stopper in hemophiliacs

Ak G., Cakir O., Kazancioglu H. O., Zulfikar B.
HAEMOPHILIA , cilt.16, ss.51, 2010 (SCI-Expanded) identifier

176. A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data

Leissinger C., Negrier C., Berntorp E., Windyga J., Serban M., Bulent A., et al.
HAEMOPHILIA , cilt.16, ss.31, 2010 (SCI-Expanded) identifier

177. NON-HODGKIN'S LYMPHOMA: 18 YEARS EXPERIENCE OF A SINGLE INSTITUTION

Kebudi R., Ayan I., Zulfikar B., Omer G., Haldun E.
PEDIATRIC BLOOD & CANCER , cilt.53, sa.5, ss.786, 2009 (SCI-Expanded) identifier

178. Dental and periodontal health in children with haemophilia

Alpkılıç Başkırt E., AK G., PINAR ERDEM A., SEPET E., ZÜLFİKAR O. B.
JOURNAL OF COAGULATION DISORDERS , sa.1, ss.1-5, 2009 (Hakemli Dergi)

179. Oral and general health-related quality of life among young patients with haemophilia

Baskirt E. A., Ak G., Zulfikar B.
HAEMOPHILIA , cilt.15, sa.1, ss.193-198, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

180. Cytomegalovirus pneumonia in a pediatric patient with solid tumor

Emiroglu H. H., Kebudi R., Zulfikar B., GÖRGÜN Ö. N. H., Yilmaz G., Ayan I., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.24, sa.2, ss.85-87, 2009 (ESCI) Sürdürülebilir Kalkınma identifier identifier

181. A Turkish multicenter retrospective study on the efficacy and safety of FEIBA in patients with hemophilia and inhibitor and other rare bleeding disorders

Zulfikar B., Aydogan G., Salcioglu Z., Oner A., Kavakli K., Gursel T.
HAEMOPHILIA , cilt.14, ss.54, 2008 (SCI-Expanded) identifier

182. The assessment of anxiety symptoms and parent attitude in children with hemophilia

Abali O., Zulfikar B., Kircelli F., Karakoc S., Gokturk U., Duman M.
HAEMOPHILIA , cilt.14, ss.146, 2008 (SCI-Expanded) identifier

183. Hemostatic management of surgical procedures with FEIBA: a Turkish case series

Zulfikar B., Kavakli K., Antmen B., Atay A., Salcioglu Z., Ar C.
HAEMOPHILIA , cilt.14, ss.54-55, 2008 (SCI-Expanded) identifier

184. Total knee arthroplasty in haemophilic patients

Dikici F., Bayansalduz A., Taier O., Zuelfikar B.
HAEMOPHILIA , cilt.14, ss.79, 2008 (SCI-Expanded) identifier

185. Oral and general health related quality of life among patients with haemophilia

Alpkilic E. B., Ak G., Zulfikar B.
HAEMOPHILIA , cilt.14, ss.35, 2008 (SCI-Expanded) identifier

186. The relationship between the level of both depression and alexithymia, and family functions and coping styles with stress in patients with hemophilia

Kutlu L., Coskun M., Duman M., Diler N., Zulfikar B.
HAEMOPHILIA , cilt.14, ss.149, 2008 (SCI-Expanded) identifier

187. Treatment of fixed flexion deformities of the knee with ilizarov circular external fixator in haemophilic patients

Dikici F., Balcy H., Erdil M., Kocaodlu M., Taper O., Zuelfikar B.
HAEMOPHILIA , cilt.14, ss.75, 2008 (SCI-Expanded) identifier

188. Vankomisine dirençli enterokok bakteriyemisi olan kanserli bir çocukta linezolid tedavisi.

Emiroğlu H., Kebudi R., Ayan İ., Güler N., Görgün Ö. N. H., Zülfikar O. B., et al.
ANKEM Dergisi , cilt.21, sa.4, ss.242-244, 2007 (Hakemli Dergi) Sürdürülebilir Kalkınma

189. Hodgkin lenfoma, tüberküloz ve otoimmün hemolitik anemili olgu: Olgu sunumu

TUĞCU D., KEBUDİ R., ZÜLFİKAR O. B., AYAN İ., GÖRGÜN Ö. N. H., AĞAN M., et al.
TURK ONKOLOJI DERGISI , cilt.22, ss.136-140, 2007 (Scopus) Sürdürülebilir Kalkınma identifier identifier

190. Second malignant tumors in childhood cancer survivors

Kebudi R., Ayan I., Gongun O., Agaoglu F. Y., Darendeliler E., Zulfikar B., et al.
PEDIATRIC BLOOD & CANCER , cilt.49, sa.4, ss.553, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

191. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid

Turkmen C., Ozturk Ş., Unal S. N., Zulrikar B., Taser O., Sanfi Y., et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , cilt.22, sa.3, ss.393-399, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

192. Rhinoplasty and hemophilia A

Oezsoy Z., Goezue A., Kul Z., Erkalp K., Zuefikar B.
AESTHETIC PLASTIC SURGERY , cilt.31, sa.1, ss.101-103, 2007 (SCI-Expanded) identifier identifier identifier

193. Monitoring the genotoxic effects of radiosynovectomy with Re-186 in paediatric age group undergoing therapy for haemophilic synovitis

Turkmen C., Ozturk Ş., Unal N., Zulfikar B., Taser O., Sanli Y., et al.
HAEMOPHILIA , cilt.13, sa.1, ss.57-64, 2007 (SCI-Expanded) identifier identifier identifier

194. Report of a case with Hodgkin's lymphoma, tuberculosis and autoimmune hemolytic anemia

TUĞCU D., KEBUDİ R., Zulfikar B., Ayan I., Agan M., GÖRGÜN Ö. N. H., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , sa.3, ss.136-140, 2007 (ESCI) Sürdürülebilir Kalkınma identifier identifier

195. The genotoxic effects in lymphocyte cultures of infants treated with radiosynovectomy by using Yittrium-90 citrate colloid.

Turkmen C., Ozturk S., Unal S., Zulfikar B., Taser O., Sanli Y., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded) identifier

196. The genotoxic effects in lymphocyte cultures of infants treated with radiosynovectomy by using Yittrium-90 citrate colloid.

Turkmen C., Ozturk S., Unal S., Zulfikar B., Taser O., Sanli Y., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.33, 2006 (SCI-Expanded) identifier

197. Home treatment of haemarthroses using a single dose regimen of recombinant activated factorVII in patients with haemophilia and inhibitors - A multi-centre, randomised, double-blind, cross-over trial

Kavakli K., Makris M., Zulfikar B., Erhardtsen E., Abrams Z., Kenet G.
THROMBOSIS AND HAEMOSTASIS , cilt.95, sa.4, ss.600-605, 2006 (SCI-Expanded) identifier identifier identifier

198. A Cost Evaluation of Treatment alternatives in Mild to Moderte Bleeding Episodes in Haemophilia Patients with Inhibitors in Turkey

ZÜLFİKAR H., ZÜLFİKAR O. B., KAVAKLI R. K.
Journal of Medical Economics , cilt.8, sa.1-4, ss.45-54, 2005 (Hakemli Dergi)

199. Circumcision in hemophilia: A cost-effective method using a novel device

Karaman M., ZÜLFİKAR O. B., Caskurlu T., Ergenekon E.
JOURNAL OF PEDIATRIC SURGERY , cilt.39, sa.10, ss.1562-1564, 2004 (SCI-Expanded) identifier identifier identifier

200. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven)

Zulfikar B., Kayiran S.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.15, sa.3, ss.261-263, 2004 (SCI-Expanded) identifier identifier identifier

201. Two patients with haemophilia and acute leukaemia

Zulfikar B.
HAEMOPHILIA , cilt.8, sa.5, ss.698-702, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

202. Medical activities in Turkey

ZÜLFİKAR O. B.
HAEMOPHILIA , cilt.6, ss.44, 2000 (SCI-Expanded) identifier

203. Circumcision ceremonies at the Ottoman Palace

Sari N., Buyukunal S., Zulfikar B.
JOURNAL OF PEDIATRIC SURGERY , cilt.31, sa.7, ss.920-924, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

204. Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: A case report

Savasan S., Zulfikar B., Ozgeneci A., ÖZBEK U., Sengun Z.
JOURNAL OF CHEMOTHERAPY , cilt.8, sa.3, ss.243-246, 1996 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

205. EWINGS-SARCOMA - EXPERIENCE WITH 12 CASES

ZULFIKAR B., GEDIKOGLU G.
JOURNAL OF CHEMOTHERAPY , cilt.4, sa.1, ss.50-55, 1992 (SCI-Expanded) identifier identifier identifier

206. THE EFFICACY OF MEZLOCILLIN-AMIKACIN COMBINATION IN FEBRILE NEUTROPENIC CHILDREN WITH ONCOLOGIC DISEASE

ZULFIKAR B., DEVECIOGLU O., ANAK S., OVALI F., GEDIKOGLU G.
JOURNAL OF CHEMOTHERAPY , cilt.3, sa.4, ss.250-254, 1991 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 155

1. Familiy Meetings in the Hemophilia Society of Turkey

ZÜLFİKAR O. B., KOÇ B., ÖZCAN H., BEZGAL F., ZÜLFİKAR H., BÜYÜKPINARBAŞILI Y.
32nd WFH 2016 World Congress, 24 - 28 Temmuz 2016, cilt.22, ss.3-138, (Özet Bildiri)

2. Profilaksi Altında Izlenen Von Willebrand Hastalarında Patojenik VWF Gen Mutasyonları

Koç Şenol S. B., Kılıç Erciyas S., Zülfikar O. B., Tunçer Ş. B.
22. Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 6 - 08 Eylül 2025, ss.74-76, (Tam Metin Bildiri)

3. Çocuklarda Kanser Nüksü: Sağlık Çalışanlarının Deneyimleri

Dalkılıç Bingöl H., AYDIN A., KEBUDİ R., ERTUNÇ SOYCAN M., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
47. Pediatri Günleri, 26. Pediatri Hemşireliği Günleri, 2. Pediatri Diyetisyenliği Günleri, 09 Nisan 2025, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Importance of Pro-Oxidant/Antioxidant Balance in the Pathogenesis of Arthropathy with Hemophilia

Bingül I., Koç Şenol S. B., Hanikoğlu A., Delen E., Ömer B., Genç S., et al.
XXXIII. WASPaLM World Congress, Antalya, Türkiye, 16 - 20 Ekim 2024, ss.95, (Özet Bildiri)

5. VWD Tanılı Hastalarda Görülen FGA Geni Mutasyonları

Kılıç Erciyas S., Tunçer Ş. B., Koç Şenol S. B., Zülfikar O. B.
21. Uluslararası Türkiye Hemofili Kongresi , İstanbul, Türkiye, 26 - 28 Eylül 2024, ss.142, (Tam Metin Bildiri)

6. Hemofilik artropati patogenezinde oksidatif stresin rolü

Bingül I., Koç Şenol S. B., Hanikoğlu A., Delen E., Ünlüçerçi Y., Genç S., et al.
21. International Hemophilia Congress of Turkiye, İstanbul, Türkiye, 26 - 28 Eylül 2024, ss.75-78, (Tam Metin Bildiri)

7. Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.

Zülfikar O. B., Malec ., Nolan B., Anthony Kc K., Albisetti M, M., Chou Sc, S., et al.
ISTH, Bangkok, Tayland, 22 - 26 Haziran 2024, ss.1, (Özet Bildiri)

8. Genetic diagnosis of Von Willebrand Disease: Preliminary results

Koç Şenol S. B., Kılıç Erciyas S., Tunçer Ş. B., Zülfikar O. B.
EAHAD 2024, Frankfurt, Almanya, 6 - 09 Şubat 2024, cilt.30, ss.127-128, (Tam Metin Bildiri) Creative Commons License

9. Von Willebrand Hastalığında Genetik Tanı: Ara sonuçları

Koç Şenol S. B., Kılıç Erciyas S., Tunçer Ş. B., Zülfikar O. B.
20. Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 1 - 03 Ekim 2023, ss.7, (Tam Metin Bildiri) Creative Commons License

10. Kalıtsal Kanama Bozuklukları Yolculuğu

ZÜLFİKAR O. B.
20th International Hemophilia Congress of Turkey, 01 Ekim 2023, (Tam Metin Bildiri)

11. What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?

MERT L., BİLGİÇ M. B., KOÇ ŞENOL S. B., ZÜLFİKAR O. B., DURMAZ H., POLAT G.
20th International Hemophilia Congress of Turkey, 1 - 03 Ekim 2023, (Tam Metin Bildiri)

12. Hemlibra Türkiye gerçek yaşam verisi

KOÇ ŞENOL S. B., AKBAYRAM S., KARAMAN K., TÜFEKÇİ GÜROCAK Ö., ANTMEN A. B., ŞAŞMAZ H. İ., et al.
20th International Hemophilia Congress of Turkey, 01 Ekim 2023, (Tam Metin Bildiri)

13. Pharmacokinetics of factor IX with one-stage and chromogenic assay in Hemophilia B and clinical outcome

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., AYDIN A. F.
20th International Hemophilia Congress of Turkey, 1 - 03 Ekim 2023, (Tam Metin Bildiri)

14. Desmopressin trial in von Willebrand disease

KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
20th International Hemophilia Congress of Turkey, 1 - 03 Ekim 2023, (Tam Metin Bildiri)

15. İnfantil fibrosarkom tanılı çocuk hastaların değerlendirilmesi: Tek merkez deneyimi

Kebudi R., Yıldırım Ü. M., Asarcıklı F., Oflaz B., Zülfikar O. B.
22. Ulusal Pediatrik Kanser Kongresi 2023 , Antalya, Türkiye, 8 - 12 Mart 2023, ss.2, (Özet Bildiri)

16. Pelvik Ewing sarkom olgularımızın değerlendirilmesi

Kebudi R., Yıldırım Ü. M., İribaş Çelik A., Zülfikar O. B., Bilgiç M. B.
22. Ulusal Pediatrik Kanser Kongresi 2023 , Antalya, Türkiye, 8 - 12 Mart 2023, ss.1, (Özet Bildiri)

17. İnflamatuar miyofibroblastik tümör tanılı çocuk hastaların değerlendirilmesi: Tek merkez deneyimi

Kebudi R., Yıldırım Ü. M., Oğuzkurt N. P., Zülfikar O. B.
22. Ulusal Pediatrik Kanser Kongresi 2023 , Antalya, Türkiye, 8 - 12 Mart 2023, ss.5, (Özet Bildiri)

18. COVID-19 pandemisi sürecinde online halk – hekim – hemofili sempozyumları

ZÜLFİKAR H., ZÜLFİKAR O. B., Dadak C., Tekinel M.
19th International Hemophilia Congress of Turkey, Antalya, Türkiye, 17 Kasım 2022, ss.141-142, (Tam Metin Bildiri)

19. Evaluation of the diagnostic accuracy of VWF:Ac and VWF Ristocetin Cofactor Activity (VWF:RCo) in the diagnosis of von Willebrand disease.

KOÇ ŞENOL S. B., Durmuş Ş. N., AKKAYA E., GENÇ N. S., ZÜLFİKAR O. B.
19th International Hemophilia Congress of Turkey, 17 Kasım 2022, (Tam Metin Bildiri)

20. The Effect of Regulatory T Cells on the Development and Pathogenesis of Inhibitors Complicating Treatment in Hemophilia A Patients.

AKKAYA E., KOÇ ŞENOL S. B., Küçüksezer U., Çetin E., Deniz G., GENÇ N. S., et al.
19th International Hemophilia Congress of Turkey, 17 Kasım 2022, (Tam Metin Bildiri)

21. Medical and Socio-Psychological Effects of The Pandemic on Patients with Herediter Bleeding Disorders and Their Treaters.

ZÜLFİKAR O. B., ZÜLFİKAR H., Gözüpek G., KOÇ ŞENOL S. B.
19th International Hemophilia Congress of Turkey, 17 Kasım 2022, (Tam Metin Bildiri)

22. “Sıfır Kanama” – ASLA PES ETME!

ZÜLFİKAR O. B.
19th International Hemophilia Congress of Turkey, Türkiye, 17 Kasım 2022, (Tam Metin Bildiri)

23. Hemofili hastalarında güvenli genel cerrahi

ERCAN L. D., Tuncak M., GÖK A. F. K., İLHAN M., YANAR H. T., GÜNAY M. K., et al.
19th International Hemophilia Congress of Turkey, Türkiye, 17 - 21 Kasım 2022, (Tam Metin Bildiri)

24. The Effects of covid-19 pandemics on patients with haemophilia and inherited bleeding disorders: results from two centers in Türkiye

GÜRLEK GÖKÇEBAY D., KOÇ ŞENOL S. B., Kurtipek F. B., Çulha V., Özbek N. Y., ZÜLFİKAR O. B.
19th International Hemophilia Congress of Turkey, Türkiye, 17 - 20 Kasım 2022, (Tam Metin Bildiri)

25. The effect of regulatory T Cells on the development and pathogenesis of inhibitors complicating treatment in hemophilia a patients

AKKAYA E., KOÇ ŞENOL S. B., KÜÇÜKSEZER U. C., ÇETİN E., DENİZ G., GENÇ N. S., et al.
19. Uluslararası Türkiye Hemofili Kongresi, Antalya, Türkiye, 17 Kasım 2022, (Tam Metin Bildiri)

26. Kalıtsal Kanama Bozukluklarında Karşılaşılan Zorluklar

ZÜLFİKAR O. B.
2th Azerbaihan International Hematology Specialist Congress, Azerbaycan, 17 Kasım 2022, (Tam Metin Bildiri)

27. Akut Lösemi Tedavi Prensipleri

ZÜLFİKAR O. B.
2th Azerbaihan International Hematology Specialist Congress, Azerbaycan, 17 Kasım 2022, (Tam Metin Bildiri)

28. Hemofilik artropatide eklem içi bevacizumab enjeksiyonunun kıkırdak ve sinovya üzerindeki etkisinin araştırılması: deneysel hayvan çalışması

Mert L., Koç Şenol S. B., Bilgiç M. B., Zülfikar O. B., Durmaz H., Polat G.
31.TOTBİD ULUSAL ORTOPEDİ VE TRAVMATOLOJİ KONGRESİ, Antalya, Türkiye, 25 - 30 Ekim 2022, cilt.56, ss.58-59, (Özet Bildiri)

29. Bereavement experiences of mothers after the death of a child with cancer: Is a new beginning possible?

AYDIN A., Dalkılıç Bingöl H., KEBUDİ R., Umaç E. H., KOÇ ŞENOL S. B., YILDIRIM Ü. M., et al.
54th Congress of the International Society of Paediatric Oncology (SIOP), 28 Eylül 2022, ss.52-53, (Özet Bildiri) Sürdürülebilir Kalkınma

30. IS A MODIFIED BFM REGIMEN WITH 1 Gram/m2 METHOTREXATE AS EFFECTIVE AS 5 Gram/m2 IN PEDIATRIC ADVANCED-STAGE NONLYMPHOBLASTIC NON-HODGKIN LYMPHOMA?

Kebudi R., Yıldırım Ü. M., Koç Şenol S. B., Zülfikar O. B.
7th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, New York, Amerika Birleşik Devletleri, 20 - 23 Ekim 2022, ss.1, (Özet Bildiri)

31. PATIENT-ORIENTED APPROACH IN THEMANAGEMENT OF HEMOPHILIA; A MULTICENTER SURVEY ONINJECTIONS WITHOUT A VIAL IN PLACE

ZÜLFİKAR H., KOÇ ŞENOL S. B., Ciga F., ZÜLFİKAR O. B.
15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual Meeting, Toronto, Kanada, 2 - 04 Şubat 2022, cilt.28, ss.76-77, (Tam Metin Bildiri)

32. Childhood Immune Thrombocytopenia: A Multicenter Questionnaire Study

ÜNÜVAR A., KARAMAN S., TUĞCU D., SEZGİN EVİM M., AKÇAY A., EKER İ., et al.
XIIth Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 10 - 13 Kasım 2021, (Özet Bildiri)

33. COCUKLUK CAGINDA ITP-TANI VE TEDAVI YAKLASIMIMIZ-COK MERKEZLI CALISMA

ÜNÜVAR A., SEZGİN EVİM M., KARAMAN S., EKER İ., TAYFUN KÜPESİZ F., Özbek N., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 4 - 07 Kasım 2021, ss.51, (Özet Bildiri)

34. Hemofili B Hastalarında Somatik Mozaiklik

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., Genç S., Genç S., YALMAN V., BERBER E.
18th International Hemophilia Congress of Turkey, 19 - 22 Eylül 2021, (Tam Metin Bildiri)

35. Real-World Evidence from the Compassionate Use Programme of EHL rFVIIIFc fusion protein (efmoroctocog alfa) in the prophylaxis and treatment of bleeding in patients with haemophilia A

ALBAYRAK C., AR M. C., EYÜPOĞLU S. A., CELKAN T. T., KÜPESİZ O. A., ŞAHİN F., et al.
18th International Hemophilia Congress of Turkey, 19 Eylül 2021, (Tam Metin Bildiri)

36. Hemofiliklerde Evlilik Kaygısı

Gümüştaş I., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
18th International Hemophilia Congress of Turkey, 19 Eylül 2021, (Tam Metin Bildiri)

37. Von Willebrand Hastalığı Tiplerinin Ayırıcı Tanısında Laboratuvar Tanısının Önemi

KOÇ ŞENOL S. B., GENÇ N. S., ÖMER B., GÜMÜŞ Ş. N., ZÜLFİKAR O. B.
18th International Hemophilia Congress of Turkey, 19 - 22 Eylül 2021, (Tam Metin Bildiri)

38. SİSLER DAĞILIRKEN - SİS ALTINDA YAPTIKLARIMIZ

ZÜLFİKAR O. B.
18th International Hemophilia Congress of Turkey, 19 Eylül 2021, (Tam Metin Bildiri)

39. Long-term Results of Repeated Radiosynovectomy in Haemophilia Patients

KOÇ ŞENOL S. B., KILIÇOĞLU Ö. İ., TÜRKMEN C., ZÜLFİKAR O. B.
18th International Hemophilia Congress of Turkey, 19 - 22 Eylül 2021, (Tam Metin Bildiri)

40. Faktör VIII ölçümünde kromojenik yöntem ve tek aşamalı yöntemin analitik performanslarının değerlendirilmesi

Akkaya E., Koç Şenol S. B., Genç N. S., Karaman S., Ömer B., Zülfikar O. B.
Uluslararası Laboratuvar Tıbbı ve XX. Ulusal Klinik Biyokimya Kongresi 25-26 Aralık 2020, İstanbul, Türkiye, 25 - 26 Aralık 2020, ss.30, (Özet Bildiri) Creative Commons License

41. Prevalence of oral diseases in patients with inherited bleeding disorders

Ak G., Yurtseven Günay A., Zülfikar O. B., Koç Şenol S. B.
17. Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 18 - 20 Aralık 2020, (Özet Bildiri)

42. Clinical problems and surgical interventions in inherited factor VII deficiency

KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
17th International Hemophilia Congress of Turkey, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

43. Harmony in Marriage And Sexual Life in Women in Famılıes with Hemophilia and Women in Families WithoutHemophilia

Gümüştaş I., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
17th International Congress of Turkey, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

44. Circumcision in Haemophilia with Inhibitors During Emicizumab Prophylaxis

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., Kara C.
17th International Hemophilia Congress of Turkey, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

45. Hemofili Hastalarında Dental İmplant Tedavileri Güvenli Midir?

AÇIKGÖZ M. M., AK G., ZÜLFİKAR O. B.
17th International Hemophilia Congress of Turkey, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

46. Dental Procedures in a Hemophiliac with Inhibitor during Emicizumab Prophylaxis

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., AK G.
17th International Hemophilia Congress of Turkey, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

47. Hareket Noktamız - Varmak Üzereyiz.

ZÜLFİKAR O. B.
17th International Congress of Turkey, online, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

48. Rhabdomyosarcoma in an Adolescent Boy With Bone Marrow Infiltration

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., BÜYÜKKAPU BAY S., AKİ H.
PEDIATRIC BLOOD CANCER, 01 Aralık 2020, (Özet Bildiri)

49. Thrombotic Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., ÖZTÜRK P.
PEDIATRIC BLOOD CANCER, 01 Aralık 2020, (Özet Bildiri)

50. Hemofili Tedavisinde Güvenlik.

ZÜLFİKAR O. B., KAVAKLI R. K.
Hemofili A Tedavisinde Dönüm Noktasına Varmak Üzereyiz Panel, online, Türkiye, 14 Ekim 2020, (Tam Metin Bildiri)

51. Peer Education Project of the Haemophilia Society of Turkey

Bezgal F., ZÜLFİKAR H., Gümüştaş I., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
WFH 2020 Congress, 14 - 19 Temmuz 2020, cilt.26, ss.101-102, (Özet Bildiri)

52. Correlation between HJHS and HEAD-US Scores during Prophylaxis in Turkish Patients with Hemophilia: National Prospective Observational Study

KAVAKLI R. K., Antmen B., EYÜPOĞLU S. A., ŞAHİN F., ZÜLFİKAR O. B., SÖNMEZ M., et al.
WFH 2020, 14 - 19 Temmuz 2020, (Tam Metin Bildiri)

53. Ülkemizde Hemlibra Klinik Çalışma Deneyimleri.

ZÜLFİKAR O. B.
Hemofili A tedavisinde dönüm noktasına varmak üzereyiz Paneli, Online, Türkiye, 22 Haziran 2020, (Tam Metin Bildiri)

54. Oral surgical approaches in patients with bleeding disorders

GÜNAY A. Y., ZÜLFİKAR O. B.
WFH 2020, 01 Haziran 2020, (Özet Bildiri)

55. Farkım Nadir Olmak, Bağ Kurmak için Elini Uzat.

ZÜLFİKAR O. B., CAMCIOĞLU Y., ARSLAN N.
Özdilek Park AVM Söyleşisi, İstanbul, Türkiye, 12 Mart 2020, (Tam Metin Bildiri)

56. Pediatrik hasta penceresinden Hemofili A. Hemofilide referans: Hemofili A hastalarının tedavisinde başarının yolu.

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
6. Hemofili Vakalarla Eğitim Sempozyumu, Antalya, Türkiye, 22 Şubat 2020, (Tam Metin Bildiri)

57. PHARMACOKINETIC-GUIDEDPROPHYLAXIS BASEDON BAYESIAN MODEL WITH MYPKFIT® IN HEMOPHILIA A:TURKISH EXPERIENCE

BALKAN C., KOÇ ŞENOL S. B., ÖZDEMİR G. N., ZÜLFİKAR O. B., KAVAKLI R. K.
EAHAD 2020, 5 - 07 Şubat 2020, cilt.26, ss.62, (Özet Bildiri)

58. PHARMACOKİNETİC-GUIDED PROPHYLAXIS BASED ON BAYESIAN MODEL WITH MYPKFIT (R) IN HEMOPHILIA A: TURKISH EXPERIENCE

BALKAN C., ALBAYRAK C., KOÇ ŞENOL S. B., ÖZDEMİR G. N., ÖZBEK N., AYTAÇ S., et al.
EAHAD 2020, 5 - 07 Şubat 2020, (Özet Bildiri)

59. HARMONY IN MARRIAGE AND SEXUAL LIFE IN WOMEN IN FAMILIES WITH HAEMOPHILIA AND WOMEN IN FAMILIES WITHOUT HAEMOPHILIA

GÜMÜŞTAŞ I., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
EAHAD 2020, 5 - 07 Şubat 2020, (Özet Bildiri)

60. Summer Camps for People with Bleeding Disorders and their Family Members in Turkey.

ZÜLFİKAR O. B.
Nort American Camping Conference of Hemopilia Organizations (NACCHO) Conference., PHOENİX, Amerika Birleşik Devletleri, 18 Ocak 2020, (Tam Metin Bildiri)

61. Current Approaches in Dental Implant Operations in Patients with Congenital Bleeding Disorder

Akbıyık Az Z. A., Yurtseven Günay A., Hacıoğlu E., Ak G., Zülfikar O. B.
TURKISH SOCIETY OF ORAL IMPLANTOLOGY 31. INTERNATIONAL SCIENTIFIC CONGRESS, İstanbul, Türkiye, 10 - 11 Ocak 2020, ss.58, (Tam Metin Bildiri)

62. Dünyada Kalıtsal Kanama Bozuklukları, Klinik Önemi ve Değişenler.

ZÜLFİKAR O. B.
55. Türk Pediatri Kongresi., Türkiye, 28 Nisan - 01 Mayıs 2019, (Tam Metin Bildiri)

63. Yüksek ve Çok Yüksek Riskli ALL Olgularında Capizzi ve Yüksek Doz Metotreksat Tedavisinin Sağkalıma Katkısı

ZÜLFİKAR O. B., YALÇIN E., KOÇ ŞENOL S. B.
23. Ulusal Kanser Kongresi, Türkiye, 17 Nisan 2019, (Tam Metin Bildiri)

64. Düzenli Takip ve Tedavi ile Hemofilik Artropati İlişkisi 20 yıllık Deneyim

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., TÜRKMEN C., Çetik G., KILIÇOĞLU Ö. İ.
16. International Hemophilia Congress, Türkiye, 14 - 17 Nisan 2019, (Özet Bildiri)

65. Ailesinde Hemofili Bulunan Kadınlarda Evlilik ve Cinsel Uyum

Gümüştaş I., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
16. International Hemophilia Congress, 14 - 17 Nisan 2019, (Tam Metin Bildiri)

66. Hemophilia and Cancer

KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
20th International Meetingof the Danubian Leagueagainst Thrombosis andHemorrhagic Disorders, 13 - 16 Nisan 2019, (Tam Metin Bildiri)

67. İnhibitörlü Hastada Minör Operasyon

KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
5. Hemofili Vakalarla Eğitim Sempozyumu, Türkiye, 22 Şubat 2019, (Tam Metin Bildiri)

68. Plasminogen deficiency with ligneous gingivitis and periodontitis

Bayar Ö., YURTSEVEN GÜNAY A., KOÇ ŞENOL S. B., ZÜLFİKAR O. B., AK G.
12th Annual Congress of European Association for Haemophilia and Allied Disorders (EAHAD) 2019, Çek Cumhuriyeti, 06 Şubat 2019, cilt.25, ss.25, (Özet Bildiri)

69. Follow-up and Treatment Expectancy and Compliance of Y-Generation Hemophiliacs

Zulfikar B., Koc B., Buyukpinarbasili Y., Bezgal F., Dadak C., Ciga F., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri) identifier

70. Good Care and Long-Term Follow-up in Young Hemophiliacs

Iscan Z., Koc B., Kilicoglu O., Atalar A., Taser O., Cetik G., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri) identifier

71. Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia - A in the Sippet Cohort Study

Peyvandi F., Bucciarelli P., Valsecchi C., Boscarino M., Palla R., Santagostino E., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132 identifier

72. Hemofilik artropatili hastalarda viskosuplementasyon tedavisi diz ve ayak bileği eklemlerinde aynı başarıyı sağlayabilir mi?

YELDAN İ., KARAKELLE S., ZÜLFİKAR O. B., KILIÇOĞLU Ö. İ.
7. Ortopedi ve Travmatoloji İstanbul Buluşması, İstanbul, Türkiye, 3 - 05 Mayıs 2018, (Tam Metin Bildiri)

73. Merkezimizde Otuz Yıl Ara ile 10’ar Yıllık Periodlarla İzlenen Ewing Sarkom Tanılı Hastalarımızın Demografik Verileri ve Klinik Sonuçlarının Karşılaştırılması.

ZÜLFİKAR O. B., KOÇ B. Ş., BÜYÜKKAPU BAY S., KOÇ ŞENOL S. B., KEBUDİ R., Özger H., et al.
TPOG, Türkiye, 2 - 06 Mayıs 2018, (Özet Bildiri)

74. Çocukluk Çağı Nazofarinks Karsinomu 1990-2018: Demografik ve Klinik Özellikleri ileUzun Dönem Tek Merkez Tedavi Sonuçları

Kebudi R., Altun M., Büyükkapu Bay S., Görgün Ö. N. H., Meral R., Ayan I., et al.
XX. Ulusal Pediatrik KanserKongresi, Antalya, Türkiye, 2 - 05 Mayıs 2018, ss.107, (Özet Bildiri)

75. Hemofililerin Etkin Spor Yapabilmeleri Üzerine Bir Eylem Araştırması

ZÜLFİKAR H., aslan d., bal b., ciga f., gümüştaş ı., demet m., et al.
15th International Hemophilia Congress of Turkey, 14 - 17 Nisan 2018, (Özet Bildiri)

76. Hemofili Bireylerde Watsu Terapisinin Etkin Kullanımı ve Fizyo-Psikolojik Etkileri

ZÜLFİKAR H., Aslan D., Bal B., Gümüştaş I., Demet M., KOÇ ŞENOL S. B., et al.
15th International Hemophilia Congress of Turkey, Türkiye, 14 - 17 Nisan 2018, (Tam Metin Bildiri)

77. Çocuk ve Genç Hemofilide Cerrahi: Tek Merkez Sonuçları.

ZÜLFİKAR O. B., İşcan Z., KILIÇOĞLU Ö. İ., KOÇ ŞENOL S. B., TÜRKMEN C., KARAMAN M. İ., et al.
15th International Hemophilia Congress of Turkey, Türkiye, 14 - 17 Nisan 2018, (Özet Bildiri)

78. EvaluatIon of oral health related qualIty of lIFe of patIents wIth haemophilia

Ak G., kavvas e., AKBIYIK AZ Z. A., YURTSEVEN GÜNAY A., Hacıoğlu E., günbatan m., et al.
15. Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 14 - 17 Nisan 2018, ss.1, (Tam Metin Bildiri)

79. People with Hemophilia A and B with Regular Care and Long-Term Follow-up Results.

KOÇ ŞENOL S. B., ZÜLFİKAR O. B., KILIÇOĞLU Ö. İ., TÜRKMEN C., Çetik G., Özcan H., et al.
15th International Hemophilia Congress of Turkey, Türkiye, 14 - 17 Nisan 2018, (Özet Bildiri)

80. Dental Implant Surgeries in Patients with Hemophilia: 4 Case Reports

Ak G., YURTSEVEN GÜNAY A., Hacıoğlu E., AKBIYIK AZ Z. A., Mustafa T., öztan a., et al.
15. Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 14 - 17 Nisan 2018, ss.1, (Tam Metin Bildiri)

81. Y Kuşağı Hemofililerde Algı Çarkları Üzerine İncelemeler

ZÜLFİKAR O. B., Ciga F., ZÜLFİKAR H., KOÇ ŞENOL S. B., Bezgal F., Büyükpınarbaşılı Y.
5th International Hemophilia Congress of Turkey, 14 - 17 Nisan 2018, (Özet Bildiri)

82. Etkin Sivil Toplum Kuruluşlarında Kurumsallaşma ve Eğitim Departmanının Önemi: Türkiye Hemofili Derneği (TRHD) Örneği

ZÜLFİKAR O. B., Yetişener H., Bezgal F., ZÜLFİKAR H., Aktaş G., Pekeş C., et al.
15th International Hemophilia Congress of Turkey, 14 - 17 Nisan 2018, (Tam Metin Bildiri)

83. Hemofili Hastalarında Profilaktik Faktör Uygulama Dozları ile Yıllık Kanama ve Dejeneratif Artropati Gelişmesi Arasındaki İlişki.

ZÜLFİKAR O. B., İşcan Z., KOÇ ŞENOL S. B., Çetik G., Özcan H., ATALAR A. C., et al.
15th International Hemophilia Congress of Turkey, Türkiye, 14 - 17 Nisan 2018, (Özet Bildiri)

84. Hemofililerin Etkin Spor Yapabilmesi Üzerine Bir Eylem Araştırması.

ZÜLFİKAR H., Aslan D., Bal B., Ciga F., Gümüştaş I., DEmet M., et al.
15th International Hemophilia Congress of Turkey., 14 - 17 Nisan 2018, (Özet Bildiri)

85. Immun Tolerance Induction in Hemophilia with Inhibitors: Istanbul Experience

Koc B., Zulfikar B., Ozdemir G. N.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130, (Özet Bildiri) identifier

86. Metabolic and Endocrin Complications of Pediatric, Adolescent and Young Adult Acute Lymphoblastic Leukemia: Single Centre Experience

Zulfikar B., Koc B., Ozturk P.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130, (Özet Bildiri) identifier

87. Hemofilide Gelecek-Uzun Etkili Faktörler

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 04 Kasım 2017

88. Bilateral Wilms Tumor, Demographic Characteristics, Treatment and Outcome: A Multicenter Study

KEBUDİ R., TUĞCU D., AKICI F., CELKAN T., VURAL S., TOKUÇ A. G., et al.
SIOP 2017 CONGRESS, 12 - 15 Ekim 2017, (Özet Bildiri)

89. A case with Factor X Deficiency and Malignant Melanoma

KOÇ ŞENOL S. B., BAY S., ZÜLFİKAR O. B., TAŞ F., KEBUDİ R.
ISTH 2017 CONGRESS, 8 - 13 Temmuz 2017, (Özet Bildiri)

90. Akut Lenfoblastik Lösemide Relaps: Tek Merkez Sonuçları

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., ÖZTÜRK P.
11. Ulusal Pediatrik Hematoloji Kongresi, Türkiye, 4 - 07 Mayıs 2017, (Özet Bildiri)

91. Hemofilik Bireylerde Psikolojik Sorunlar ve Yaklaşım

GÜMÜŞTAŞ I., ZÜLFİKAR H., KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

92. Türkiye’de Faktör 9 Geni Mutasyon Profili

ÇOLAKOĞLU ÖZKAYA Ş., KOÇ ŞENOL S. B., BERBER E., ZÜLFİKAR O. B.
14. Türkiye Hemofili Kongresi, Türkiye, 15 Nisan 2017, (Özet Bildiri)

93. HEMOFILI HASTALARININ TOPLUMA ENTEGRASYONU VE BAŞARI PERFORMANSLARINDA YÜZME SPORUNUN ETKIN KULLANIMI

ZÜLFİKAR H., ASLAN D., BAL B., CİGA F., GÜMÜŞTAŞ I., METE D., et al.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

94. Hemofili Hastalarının Topluma Entegrasyonu ve Başarı Performanslarında Yüzme Sporunun Etkin Kullanımı

ZÜLFİKAR H., Duran A., Bal B., Ciga F., Gümüştaş I., Mete D., et al.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

95. HEMOFILILERDE SPOR ETKINLIKLERINE DÜZENLI KATILIM VE GRUPAIDIYETI ÜZERINE BIR MODELLEME

ZÜLFİKAR H., ASLAN D., BAL B., CİGA F., GÜMÜŞTAŞ I., METE D., et al.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

96. ULUSLARARASI KARDEŞ DERNEK ÇALIŞMALARI

ZÜLFİKAR O. B., BÜYÜKPINARBAŞILI Y., KOÇ ŞENOL S. B., BEZGAL F.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

97. HEMOFILIKLERDE SPOR AKTIVITELERI: GÖZLEMSEL ÇALIŞMA

KARA S., ZÜLFİKAR O. B., ÖZDEMİR G. N., KOÇ ŞENOL S. B., ÖZCAN H.
14. Türkiye Hemofili Kongresi, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

98. Hemofili Kamplarında İlk Gün Etkinliklerinin Özel Tasarlanması Üzerine Yeni Bir Yaklaşım

ZÜLFİKAR H., BAL B., CİGA F., GÜMÜŞTAŞ I., DEMET M., KOÇ ŞENOL S. B., et al.
14. Türkiye Hemofili Kongresi / Kongre Kitabı, Türkiye, 12 - 15 Nisan 2017, (Özet Bildiri)

99. Hemofililerde Spor Etkinliklerine Düzenli Katılım ve Grup Aidiyeti Üzerine Bir Modelleme

ZÜLFİKAR H., arslan d., bal b., ciga f., Irmak G., Mete D., et al.
14. Türkiye Hemofili Kongresi / Kongre Kitabı, Türkiye, 12 - 15 Nisan 2017, (Tam Metin Bildiri)

100. Aort Coarctation in Severe Hemophilia B

KOÇ ŞENOL S. B., YÜCEL İ. K., ÇELEBİ A., ZÜLFİKAR O. B.
EAHAD 2017 CONGRESS, Fransa, 1 - 03 Şubat 2017, cilt.23, ss.42, (Özet Bildiri)

101. An Ancient Complication of Hemophilia:Pseudotumor

ZÜLFİKAR O. B., KILIÇOĞLU Ö. İ., EMEKLİ U., KOÇ ŞENOL S. B., BEZGAL F., KİZİR A.
EAHAD 2017 CONGRESS, Fransa, 1 - 03 Şubat 2017, cilt.23, ss.45-46, (Özet Bildiri)

102. Risk Adapted Treatment in Childhood Hodgkin's Lymphoma: Outcome and Changing Epidemiologic Features in 25 Years

Kebudi R., Buyukkapu S. B., Gorgun O., Agaoglu F. Y., Zulfikar B., Ayan I., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri) identifier

103. Second malignancies in childhood cancer survivors.

Kebudi R., Gorgun O., Ayan I., Agaoglu F. Y., Kebudi A., Zulfikar B., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

104. Bölgesel Hemofili Sempozyumları

ZÜLFİKAR O. B., BÜYÜKPINARBAŞILI Y., KILIÇOĞLU Ö. İ., AK G., KOÇ B., BERBER E., et al.
13.ULUSLARARASI TÜRKİYE HEMOFİLİ KONGRESİ, İstanbul, Türkiye, 17 - 19 Nisan 2016, cilt.2, ss.302-303, (Özet Bildiri)

105. Aile Toplantıları TRHD

ZÜLFİKAR O. B., KOÇ B., ÖZCAN H., BEZGAL F., ZÜLFİKAR H., BÜYÜKPINARBAŞILI Y.
13. ULUSLARARASI TÜRKİYE HEMOFİLİ KONGRESİ, İstanbul, Türkiye, 17 - 19 Nisan 2016, cilt.2, ss.301, (Özet Bildiri)

106. Türkiye deki Hemofilik Bireylerin Sağlık Araştırmaları Hakkında Sosyal Medya KullanımAlışkanlıkları

DADAK C., ZÜLFİKAR H., KOÇ B., ÇIKAN A., ZÜLFİKAR O. B.
13.Uluslararası türkiye Hemofili Kongresi, İstanbul, Türkiye, 17 - 19 Nisan 2016, cilt.2, ss.310-311, (Özet Bildiri)

107. Her Yaştan Katılımcı İle Yaş Yakınsamalı Kamp Tasarımı

ZÜLFİKAR H., KILIÇASLAN Ş., AYDOĞAN A., DADAK C., BÜYÜKPINARBAŞILI Y., BEZGAL F., et al.
13.ULUSLARARASI TÜRKİYE HEMOFİLİ KONGRESİ, İstanbul, Türkiye, 17 - 19 Nisan 2016, cilt.2, ss.312-318, (Tam Metin Bildiri)

108. Hemofilik Bireylerin İnternet Üzerinden Sağlık Bilgisi Edinme Tutum ve Davranışları

ZÜLFİKAR H., METE D., DADAK C., MUTLU A., BİLGE B., ZÜLFİKAR O. B.
13. ULUSLARARASI TÜRKİYE HEMOFİLİ KONGRESİ, İstanbul, Türkiye, 17 - 19 Nisan 2016, cilt.2, ss.319-327, (Tam Metin Bildiri)

109. Hemophilic Arthropathy in Inhibitor Positive Hemophilia Patients

ZÜLFİKAR O. B., KILIÇOĞLU Ö. İ., ATALAR A. C., KOÇ ŞENOL S. B., Bezgal F., Özcan H., et al.
EAHAD 2016, İsveç, 03 Şubat 2016, cilt.22, ss.85-86, (Özet Bildiri)

110. Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Peyvandi F., Mannucci P. M., Garagiola I., Elalfy M., El-Beshlawy A., Ramanan M. V., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri) identifier

111. Vincristine, Irinotecan And Temozolomide Treatment For Recurrent/Progressive Pediatrıc Solid Tumors

KEBUDİ R., BÜYÜKKAPU BAY S., ÇAKIR F. B., GÖRGÜN Ö. N. H., KOÇ ŞENOL S. B., ZÜLFİKAR O. B., et al.
47th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Güney Afrika, 08 Ekim 2015, (Özet Bildiri)

112. Childhood Ewing Sarcoma Family Tumors: 25-Year Experience Of A Single Center In Turkey

KEBUDİ R., GÖRGÜN Ö. N. H., ÇAKIR F. B., Yaman Ağaoğlu F., BÜYÜKKAPU BAY S., KOÇ ŞENOL S. B., et al.
47th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Güney Afrika, 08 Ekim 2015, (Özet Bildiri)

113. Prophylactic approach to reccurrent bleeding in hemophilia with inhibitors

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., ÖZDEMİR G. N.
ISTH 2015 Congress, Kanada, 20 Haziran 2015, (Özet Bildiri)

114. Philedelphia Pozitif Çocukluk Çağı Akut Lenfoblastik Lösemilerinde Birinci ve İkinci Jenerasyon Tirozin Kinaz İnhibitörlerinin Rolü

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
10. Ulusal Pediatrik Hematoloji Kongresi, Türkiye, 03 Haziran 2015, (Özet Bildiri)

115. Excellent Overall Survival (100%) in Turkish Children with Standart Risk Acut Lymphoblastik Leukemia

ZÜLFİKAR O. B., ÇAKIR F. B., KOÇ ŞENOL S. B.
28th Annual Meeting of American Society Pediatric Hematology/Oncology, Amerika Birleşik Devletleri, 06 Mayıs 2015, (Özet Bildiri)

116. Surgical Interventions In Patients With Factor VII Deficiency

Koc B., Ozdemir G. N., Celkan T., Zulfikar B.
8th Annual Congress of the European-Association-for-Haemophilia-and-Allied-Disorders, Helsinki, Finlandiya, 11 - 13 Şubat 2015, cilt.21, ss.77, (Özet Bildiri) identifier

117. Benefits Of Radius Head Resection In Patients With Haemophilia

Zulfikar B., Ersen A., Koc B., Atalar A. C.
8th Annual Congress of the European-Association-for-Haemophilia-and-Allied-Disorders, Helsinki, Finlandiya, 11 - 13 Şubat 2015, cilt.21, ss.79-80, (Özet Bildiri) identifier

118. invaziv pulmoner aspergillos tedavisinde kombine antifungal kullanımı vaka sunumu

SÜTÇÜ M., bay s., koç b., HANÇERLİ TÖRÜN S., AKTÜRK H., erol b., et al.
7.pediatrik febril nötropeni sempozyumu, Türkiye, 7 - 09 Kasım 2014

119. İnvaziv Pulmoner Aspergillosis Tedavisinde Kombine Antifungal Kullanımı

SÜTÇÜ M., BÜYÜKKAPI BAY S., KOÇ B., HANÇERLİ TÖRÜN S., AKTÜRK H., EROL O. B., et al.
7.Pediyatrik Febril Nötropeni Sempozyumu, Türkiye, 7 - 09 Kasım 2014

120. INFECTIONS WITH RESPIRATORY VIRUSES IN CHILDREN WITH CANCER IN ISTANBUL

KEBUDİ R., KAPU s. b., SÖZMEN B. O., CIBLAK M., GÖRGÜN Ö. N. H., ZÜLFİKAR O. B., et al.
46th IMeeting of the International Society of Pediatric Oncology, Toronto, Kanada, 22 - 25 Ekim 2014, ss.102, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

121. NASOPHARENGEAL CARCINOMA IN CHILDREN AND ADOLESCENTS 1989-2014: DEMOGRAPHIC, CLINICAL, THERAPEUTICAL CHARACTERISTICS AND LONG TERM OUTCOME

Kebudi R., Meral R., Görgün Ö. N. H., Çakır F. B., Çelikaslan S., Ayan I., et al.
46th Congress of the International Society of Pediatric Oncology, Toronto, Kanada, 22 - 25 Ekim 2014, ss.109, (Tam Metin Bildiri)

122. Elective major surgery in hemophiliacs: Istanbul experience

TÜYSÜZ KİNTRUP G., ZÜLFİKAR O. B., KILIÇOĞLU Ö. İ., DİKİCİ F., KOÇ ŞENOL S. B., Bezgal F., et al.
WFH 2014 World Congress, Avustralya, 11 Mayıs 2014, (Özet Bildiri)

123. Long-term results of radiosynovectomy in the treatment of hemophilic synovitis: experience in Istanbul

ZÜLFİKAR O. B., TÜRKMEN C., KILIÇOĞLU Ö. İ., ÇAKIR F. B., KOÇ ŞENOL S. B., DİKİCİ F., et al.
WFH 2014 World Congress, Avustralya, 11 Mayıs 2014, (Özet Bildiri)

124. Türkiye Örneğinde Konsepte Dayalı Hemofili Kamp Modellemesi MOCC

ZÜLFİKAR O. B., Bezgal F., Kılıçaslan Ş., Çakmakçı S., Büyükpınarbaşılı Y., ZÜLFİKAR H., et al.
11.Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 17 - 20 Nisan 2014, ss.153-155

125. Hemofili Hastalarında İntrakranial Kanama

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., Bezgal F., KIRIŞ T., ÖZEK Ö. M. M.
11. Uluslararası Türkiye Hemofili Kongresi, Türkiye, 17 Nisan 2014, (Özet Bildiri)

126. Hemofili Sivil Toplum Kuruluşlarında Merkezlerin Fiziki Planlaması Türkiye Hemofili Derneği Örneği

ZÜLFİKAR O. B., Bali F., Bezgal F., Büyükpınarbaşılı Y., ZÜLFİKAR H., Kılıçaslan Ş.
11.Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 17 - 20 Nisan 2014, ss.156-157

127. Hemofiliklerin Yaşama ve Hemofiliye İlişkin Değerlendirmeleri

ZÜLFİKAR H., Büyükpınarbaşılı Y., Bezgal F., Berber E., Kılıçaslan Ş., Bali F., et al.
11.Uluslararası Türkiye Hemofili Kongresi, İstanbul, Türkiye, 17 - 20 Nisan 2014, cilt.1, ss.133-139

128. Operative management and outcomes in haemophilia with inhibitor

ZÜLFİKAR O. B., KOÇ ŞENOL S. B., KILIÇOĞLU Ö. İ., TÜRKMEN C., DİKİCİ F., AK G., et al.
EAHAD 2014, Belçika, 28 Şubat 2014, (Özet Bildiri)

129. Childhood nasopharyngeal carcinoma: 24 year experience of a single center in Turkey

Kebudi R., Meral R., Çakır F. B., Çelikarslan Ş., Zülfikar O. B., Yaman Ağaoğlu F., et al.
6th International Symposium on nasopharyngeal carcinoma 20-22 june 2013, İstanbul, Abstract book, poster abstracts P-13, p 105, İstanbul, Türkiye, 20 - 22 Haziran 2013, ss.66-67, (Özet Bildiri)

130. Pediatrik Febril Nötropenide 20 Yıllık Deneyim: Tek Merkez Sonuçları

KEBUDİ R., GÖRGÜN Ö. N. H., KOÇ ŞENOL S. B., ZÜLFİKAR O. B., ÖZDEMİR G. N., TÜYSÜZ KİNTRUP G., et al.
9. Ulusal Pediatrik Hematoloji Kongresi, Türkiye, 24 Mayıs 2013, ss.9, (Özet Bildiri)

131. Non-Hodgkin lymphoma in children: Is 1 g/m2 methotrexate as effective as 5 g/m2 in advanced-stage nonlymphoblastic non-Hodgkin lymphoma

Kebudi R., Zulfikar B., Cakir F. B., Gorgun O., Ayan I., Dogan O.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) identifier

132. Desmoplastic Fibroma of the Mandible:Review of the Literature and Presentation of A case

AK G., ZÜLFİKAR B., ŞENOL GÜVEN G., AÇIKGÖZ M. M., ÖZER N.
6th International Congress of Turkish Oral And Maxillofacial Surgery Society, Antalya, Türkiye, 30 Mayıs - 02 Haziran 2012, (Tam Metin Bildiri)

133. Current Surgical Procedures for Hemophilic Patients: Case Series and Literature Review.

AK G., ZÜLFİKAR B., ŞENOL GÜVEN G., AÇIKGÖZ M. M.
6th International Congress of Turkish Oral And Maxillofacial Surgery Society, Antalya, Türkiye, 30 Mayıs - 02 Haziran 2012, (Tam Metin Bildiri)

134. Diffuse pontine gliomas in children: Do changing strategies change results?

Kebudi R., Cakir B., Agaoglu F. Y., Darendeliler E., Gorgun O., Dagoglu N., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) identifier

135. Kronik Hemofilik Sinovit Tedavisinde Re 186 Kolloid ile Yapılan Radyosinovektomi Sonrası Eklem İçi Radyofarmasötik Dağılımının Tedavi Yanıtı ile İlişkisinin Karşılaştırılması

IŞIK E. G., ŞANLI Y., KUYUMCU S., YILMAZ E., ÖZKAN Z. G., BEZGAL F., et al.
24. Ulusal Nükleer Tıp Kongresi, Türkiye, 4 - 08 Nisan 2012, ss.15

136. Prophylactic Dosing of Anti-Inhibitor Coagulant Complex (FEIBA) Reduces Bleeding Frequency In Hemophilia A Patients with Inhibitors: Results of the Pro-FEIBA Study

Leissinger C. A., Berntorp E., Biasioli C., Carpenter S., Jo H., Kavakli K., et al.
52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 4 - 07 Aralık 2010, cilt.116, ss.317-318, (Özet Bildiri) identifier

137. IS ANKAFERD BLOOD STOPPER AN ALTERNATIVE COAGULATION METHOD FOR AFTER HEMOPHILIC PATIENTS

AK G., ZÜLFİKAR B., KAZANCIOĞLU H. O., ÇAKIR O., KILIÇ S., ERÇETİN S.
BIENNIAL CONGRESS OF THE EUROPEAN ASSOCIATION OF ORAL MEDICINE, Salzburg, Avusturya, 18 - 20 Eylül 2008, (Tam Metin Bildiri)

138. The Relationship between the level of both depression and alexithymia, and family functions and coping styles with stres in patients with hemophlia

Kutlu L., COŞKUN M., ZÜLFİKAR O. B.
XXVIII International Congress of The World Federation Hemophilia, İstanbul, Türkiye, 1 - 05 Haziran 2008, ss.149, (Tam Metin Bildiri)

139. Hemophilia World Congress 2008 bildiri kitapçığındaki A Turkish Multicenter retrospective Study on Efficacy and Safety of FEIBA in Patients with Hemophilia and Inhibitors or Other Rare Bleeding Disorders

ZÜLFİKAR O. B., Aydoğan G., Şalcıoğlu Z., Öner A. F., KAVAKLI R. K., Gürsel T., et al.
28th Internatonal Congress of the World Federation of Hemophilia, İstanbul, Türkiye, 1 - 05 Haziran 2008, ss.20

140. Fibrin sealants and tissue adhesives as local haemostatic agents in patients with bleeding disorders

AK G., ALPKILIÇ E., KÜRKLÜ E., KORAY M., TANYERİ H., ZÜLFİKAR O. B.
8th Biennial Congress of the European Association of Oral Medicine, Hırvatistan, (Tam Metin Bildiri)

141. DENTAL MANAGEMENT OF PATİENTS WİTH BLEEDİNG DİSORDERS İN A DEVELOPİNG COUNTRY

AK G., Alpkılıç Başkırt E., ZÜLFİKAR O. B.
27.INTERNATIONAL CONGRESS OF THE WFH, Vancouver, Kanada, 21 - 25 Mayıs 2006, (Tam Metin Bildiri)

142. A CASE REPORT:APPLİCATİON OF B-TRİCALCİUM PHOSPHATE İN A HAEMOPHİLİAC PATİENT FOR A DENTAL SURGİCAL OPERATİON

AK G., Alpkılıç Başkırt E., ZÜLFİKAR O. B.
27.INTERNATIONAL CONGRESS OF THE WFH, Vancouver, Kanada, 21 - 25 Mayıs 2006, (Tam Metin Bildiri)

143. The application of physical treatments and rehabilitation program in hemophilic patients

Zülfikar O. B., Taşer Ö., Metin Ö., Gündoğdu G., Ergin Ö. N.
9th World Federation of Hemophilia Musculoskeletal Congress, İstanbul, Türkiye, 9 - 11 Eylül 2005, ss.292-293, (Özet Bildiri) Creative Commons License

144. External fixator applications for the deformities resulting from hemophilic knee arthropathies

Kocaoğlu M., Zülfikar O. B., Ergin Ö. N., Taşer Ö.
9th World Federation of Hemophilia Musculoskeletal Congress, İstanbul, Türkiye, 9 - 11 Eylül 2005, ss.295, (Özet Bildiri) Creative Commons License

145. The Evaluation of Fibrin Glue and Synthetic Fibrin Adhesives as Local Haemostatic Agent in Haemoohiliac Patients

AK G., ALPKILIÇ E., KÜRKLÜ E., KORAY M., TANYERİ H., ZÜLFİKAR O. B.
7th Biennial Congress of the European Association of Oral Medicine & 26th Annual Scientific Meeting of the Academy of Oral Pathology and Oral Medicine (AKOPOM), Almanya, ss.38, (Tam Metin Bildiri)

146. Hemofililerin Eklem Sorunlarında Artroskopik ve Radyoaktif Sinevektominin Farmako-Ekonomik Karşılaştırılması

ZÜLFİKAR O. B., Taşer ö., ZÜLFİKAR H., TÜRKMEN C.
31. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 23 - 28 Eylül 2004, (Tam Metin Bildiri)

147. Hemofililerde Sünnet ve Farmakoekonomisi

ZÜLFİKAR O. B., KARAMAN M. İ., ZÜLFİKAR H.
31.Ulusal hematoloji Kongresi, Antalya, Türkiye, 23 - 28 Eylül 2004, (Tam Metin Bildiri)

148. Radiosynovectomy in patients with hemophilic synovitis

Turkmen C., Zulfikar B., Taser O., Tokmak H., Mudun A., Unal S., et al.
17th Annual Congress of the European-Association-of-Nuclear-Medicine, Helsinki, Finlandiya, 4 - 08 Eylül 2004, cilt.31 identifier

149. An economic evaluation of alternatives in the management of mild/moderate bleeding episodes in hemophilia patients with inhibitors to clotting factors VIII and IX in Turkey.

Kavakli K., Dundar S., Zulfikar B., Gonen C., Zulfikar H., Yilmaz D., et al.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri) identifier

150. An Economic Evaluation of Alternatives in the Managements an Mild Modrate Bleeding Episodes in Hemophilia Patients within Inhibitors to Clotting Factors VIII and IX in Turkey

KAVAKLI R. K., DÜNDAR S., Gönen C., ZÜLFİKAR O. B., ZÜLFİKAR H., Yılmaz D., et al.
45th ASH Annual Meeting, San Diego, Amerika Birleşik Devletleri, 6 - 09 Haziran 2003, cilt.102, ss.96, (Özet Bildiri)

151. TOOTH EXTRACTİON İN COAGULATİON DİSORDERS

AK G., ZÜLFİKAR B., GÜÇ Ü.
25.INTERNATİONAL OF THE WFH, Sevilla, İspanya, 19 - 24 Mayıs 2002

152. ORAL CONDİTİON OF PATİENTS WİTH CONGENİTAL COAGULATİON DİSORDERS

AK G., ZÜLFİKAR B., FIRATLI E., TANYERİ H., ÖZDEMİR Ö.
25.INTERNATİONAL OF THE WFH, Sevilla, İspanya, 19 - 24 Mayıs 2002, (Tam Metin Bildiri)

153. Parvovirus B19 antibodies in patients with hemophilia

ZÜLFİKAR O. B., Ermiş B., Özgenç R., Özdemir Ö., Ovalı F., ÖZTÜRK R.
9th Annual European Hemophilia Consortium Conference, İstanbul, Türkiye, 8 - 10 Kasım 1996, ss.29, (Özet Bildiri)

154. Antibodies to cytomegalovirus and HIV infection in a hemophilic cohort

Özdemir Ö., İlter M., Akdeniz C., ÖZTÜRK R., ZÜLFİKAR O. B.
9th Annual European Hemophilia Consortium Conference, İstanbul, Türkiye, 8 - 10 Kasım 1996, ss.32 Sürdürülebilir Kalkınma

155. İstanbul’da değişik yaş grubundan sağlıklı kişiler, hamileler, diş hekimleri ve berberlerde hepatit-B taraması sonuçları

Zülfikar O. B., Öztürk R., Kınık K., Öçlü F., Mert A., Aydın Ö. F., et al.
III. Ulusal Viral Hepatit Sempozyumu, Ankara, Türkiye, 7 - 09 Kasım 1996, ss.20, (Özet Bildiri) Sürdürülebilir Kalkınma
Kitaplar 8

1. Hemorajik Diyatez ve Travma

Koç Şenol S. B., Zülfikar O. B.
Travma, Cemalettin Ertekin, Editör, EMA Tıp Kitabevi, İstanbul, ss.653-668, 2022

2. Serebral Sinüs Ven Trombozu olan T-hücreli Akut Lenfoblastik Lösemi Tanılı Olgu

KOÇ ŞENOL S. B., ZÜLFİKAR O. B.
Çocuk Hematolojide Olgularla Tromboz., Namık Yaşar Özbek, Hale Ören, Ayşegül Ünüvar, Editör, Galenos Yayın Evi, ss.118-119, 2020

3. Çocukluk Çağı Tiroid Kanserleri

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
Temel Pediatri, Hasanoğlu Enver, Düşünsel Ruhan, Bideci Aysun, Boduroğlu Koray, Editör, Güneş Tıp Kitabevi, ss.1972-1973, 2020

4. Akut Lösemiler-Ayırıcı Tanı

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
Akut Lösemiler, Demir, Ahmet Muzaffer, Editör, Galenos, ss.341-345, 2017

5. Pıhtılaşma Bozuklukları

Zülfikar B., KOÇ ŞENOL S. B.
Pediatrinin Esasları, Erkan T, Kutlu T, Satar M, Ünüvar E, Editör, İstanbul Tıp Kitabevi, İstanbul, ss.757-766, 2016

6. Pıhtılaşma Bozuklukları

ZÜLFİKAR O. B., KOÇ ŞENOL S. B.
Pediatrinin Esasları, Erkan Tülay, Kutlu Tufan, Satar Mehmet, Ünüvar Emin, Editör, İstanbul Medikal Sağlık ve Yayıncılık, ss.757-766, 2016

7. Akut Lösemiler - Ayırıcı Tanı.

Zülfikar B., KOÇ ŞENOL S. B.
Hematolog-Akut Lösemiler, Demir M, Editör, Türk Hematoloji Derneği, İstanbul, ss.341-345, 2016

8. Yemek Üreticisinin El Kitabı

ZÜLFİKAR O. B., ÖZTÜRK R., Heperken D., BOYACIOĞLU D.
İstanbul Büyükşehir Belediyesi Sağlık Daire Başkanlığı Yayınları ( No.6), İstanbul, 1996
Metrikler

Yayın

369

Yayın (WoS)

207

Yayın (Scopus)

194

Atıf (WoS)

1296

H-İndeks (WoS)

17

Atıf (Scopus)

1550

H-İndeks (Scopus)

18

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

29

Proje

50

Tez Danışmanlığı

5

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları